<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS154565</article-id><article-id pub-id-type="doi">10.1101/2021.12.12.472321</article-id><article-id pub-id-type="archive">PPR431920</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Insights into the role of lipoteichoic acids and MprF function in <italic>Bacillus subtilis</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Guyet</surname><given-names>Aurélie</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Alofi</surname><given-names>Amirah</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Daniel</surname><given-names>Richard A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Centre for Bacterial Cell Biology, Baddiley-Clark Building, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Richardson Road, Newcastle upon Tyne NE2 4AX, United Kingdom</aff><author-notes><corresp id="CR1"><label>*</label>For correspondence <email>aurelie.guyet@newcastle.ac.uk</email> and <email>richard.daniel@newcastle.ac.uk</email> Tel. +44 1912 083239.</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>19</day><month>09</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>18</day><month>09</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Gram-positive bacterial cells are protected from the environment by a cell envelope which comprises of layers of peptidoglycan that maintain the cell shape and teichoic acids polymers whose biological function remains unclear. In <italic>Bacillus subtilis</italic>, loss of all Class A Penicillin-Binding Proteins (aPBPs) which function in peptidoglycan synthesis is conditionally lethal. Here we show that this lethality is associated with an alteration of the lipoteichoic acids (LTA) and the accumulation of the major autolysin LytE in the cell wall. Our analysis provides further evidence that the length and abundance of LTA acts to regulate the cellular level and activity of autolytic enzymes, specifically LytE. Importantly, we identify a novel function for the aminoacyl-phosphatidylglycerol synthase MprF in the modulation of LTA biosynthesis in <italic>B. subtilis</italic> and <italic>Staphylococcus aureus</italic>. This finding has implications for our understanding of antimicrobial resistance (particularly daptomycin) in clinically relevant bacteria and the involvement of MprF in the virulence of pathogens, such as methicillin resistant <italic>S. aureus</italic>.</p></abstract><kwd-group><kwd><italic>Bacillus</italic></kwd><kwd>LTA</kwd><kwd>LytE</kwd><kwd>MprF</kwd><kwd>PBP1</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Gram-positive bacteria have a common cell envelope architecture that contributes to maintaining cell shape and protects the cell from environmental changes. The best characterised component of the cell envelope is the peptidoglycan (PG) which forms a mesh like structure enclosing the cell membrane. Onto this structure anionic polymers are either covalently attached to PG N-acetylmuramic acids and known as wall-teichoic acids (WTA, <xref ref-type="fig" rid="F1">Fig 1A</xref>) or are tethered to the external face of the membrane and named lipoteichoic acids (LTA) (<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R4">4</xref>). It is unclear whether LTA are localized in a periplasm-like space between the membrane and PG or extend through the PG layers (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R6">6</xref>).</p><p id="P3">Peptidoglycan is synthetised by glycosyltransferases (GTases) which catalyse the addition of a disaccharide pentapeptide precursor (lipid II), to the nascent PG chain (<xref ref-type="fig" rid="F1">Fig 1A</xref>) while transpeptidase (TPase) enzymes cross-link a proportion of the pentapeptides to adjacent PG strands (<xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref>). In the absence of the bifunctional transmembrane GTase and TPase enzymes, known as class A Penicillin-Binding Proteins (aPBPs) (<xref ref-type="fig" rid="F1">Fig 1A</xref>), <italic>B. subtilis</italic> cells are viable but the cells are longer and thinner and are prone to lysis (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R10">10</xref>). The viability of <italic>B. subtilis</italic> lacking all aPBPs (referred as <italic>Δ4</italic>) depends on the functionality of the essential protein RodA that was recently identified to function as a PG glycosyltransferase (<xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R12">12</xref>). The <italic>Δ4</italic> strain is conditionally lethal on PAB agar medium unless supplemented with magnesium (<xref ref-type="bibr" rid="R10">10</xref>). It is thought that this divalent cation alters the structure of the wall by binding to teichoic acids or PG and by doing so, might alter the activity of cell wall hydrolases (<xref ref-type="fig" rid="F1">Fig 1A</xref>), the enzymes that modify and sculpt synthesised PG to allow the cell to elongate and divide (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R15">15</xref>).</p><p id="P4">In rod-shaped <italic>B. subtilis</italic> 168, LTA and WTA are composed of polyglycerolphosphate (polyGroP) generated by independent biosynthetic pathways (<xref ref-type="fig" rid="F1">Fig 1B</xref>) (<xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R5">5</xref>). Importantly, <italic>B. subtilis</italic> is not able to survive the loss of both LTA and WTA synthesis (<xref ref-type="bibr" rid="R16">16</xref>) and these teichoic acids seem to have roles in both cell growth (<xref ref-type="bibr" rid="R17">17</xref>) and division-separation (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R18">18</xref>). It has also been determined that anionic charge of these polymers can be modified by the addition of D-alanine or N-acetylglucosamine (<xref ref-type="bibr" rid="R19">19</xref>). D-alanylation by Dlt proteins (<xref ref-type="fig" rid="F1">Fig 1A</xref>) is proposed to regulate autolysin activity, cell wall ion homeostasis (<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R5">5</xref>) and also imparts some resistance to positively charged cationic antimicrobial peptides (CAMPs) (<xref ref-type="bibr" rid="R20">20</xref>). The net cell envelope charge is proposed to be moderated by the teichoic acids and also the phospholipid composition of the cell membrane (<xref ref-type="fig" rid="F1">Fig 1</xref>) (<xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R22">22</xref>). In this respect, the transmembrane protein MprF is the only enzyme known to synthesise and translocate aminoacyl-phosphatidylglycerol (aaPGol), in particular lysyl-PGol (<xref ref-type="fig" rid="F1">Fig 1</xref>) (<xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R26">26</xref>). MprF plays a role in the virulence of bacterial pathogens (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref>) and in <italic>B. subtilis</italic>, it confers resistance to CAMPs (<xref ref-type="fig" rid="F1">Fig 1A</xref>) such as nisin and daptomycin through mechanisms that are not yet characterized (<xref ref-type="bibr" rid="R28">28</xref>, <xref ref-type="bibr" rid="R29">29</xref>). Phosphatidylglycerol (PGol) is also the substrate for LTA-synthases, in <italic>B. subtilis</italic> three of these enzymes are present: LtaS (‘house-keeping’), YfnI (‘stress’) and YqgS (‘sporulation’) (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R18">18</xref>) (<xref ref-type="fig" rid="F1">Fig 1</xref>). These transmembrane LTA-synthases have an extracellular catalytic domain that uses PGol to generate a polyGroP polymer on a lipid anchor (<xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R3">3</xref>). The lipid anchor is usually a diglucosyldiacylglycerol (Glc<sub>2</sub>DAG) produced by UgtP on the internal surface of the cell membrane (<xref ref-type="bibr" rid="R30">30</xref>) (<xref ref-type="fig" rid="F1">Fig 1A</xref>). As an <italic>ugtP</italic> mutant still produces LTA (<xref ref-type="bibr" rid="R31">31</xref>), it suggests that polyGroP polymers are probably anchored to a phosphatidylglycerol as observed in <italic>Staphylococcus aureus</italic> (<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R33">33</xref>).</p><p id="P5">In <italic>S. aureus</italic>, LTA is essential and seems to modulate autolytic activity (<xref ref-type="bibr" rid="R34">34</xref>), while WTA is dispensable but appears to restrict autolytic activity (<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R4">4</xref>). Contrary to <italic>B. subtilis</italic>, <italic>S. aureus</italic> has only one LTA-synthase (LtaS) whose absence is (conditionally) essential (<xref ref-type="bibr" rid="R35">35</xref>) and can be complemented by <italic>B. subtilis ltaS</italic> but not <italic>yfnI</italic> (<xref ref-type="bibr" rid="R18">18</xref>, <xref ref-type="bibr" rid="R36">36</xref>). A recent <italic>in vitro</italic> study showed that <italic>S. aureus</italic> LtaS is processive and that the LTA polymer elongation is directly regulated by the identity and concentration of lipid starter units. Interestingly, use of Glc<sub>2</sub>DAG as a starter unit led to the formation of shorter polymers (<xref ref-type="bibr" rid="R33">33</xref>) while the use of PGol resulted in the synthesis of longer polymers. It is not clear if this newly identified mechanism might be conserved in <italic>B. subtilis.</italic> However, in absence of <italic>B. subtilis</italic> LtaS, YfnI activity results in LTA of increased length and it is possible that the combination of LtaS and YfnI activities modulated the length of LTA (<xref ref-type="fig" rid="F1">Fig 1A</xref>) (<xref ref-type="bibr" rid="R18">18</xref>, <xref ref-type="bibr" rid="R37">37</xref>).</p><p id="P6">Through characterising <italic>B. subtilis</italic> strains lacking peptidoglycan GTase activity (<xref ref-type="bibr" rid="R12">12</xref>), we aimed to understand the cell wall stresses causing aPBP mutants to lyse on glucose rich media. Collectively, our data supports the idea that in <italic>B. subtilis</italic> LTA length acts to moderate the activity of at least one important autolysin, LytE (<xref ref-type="fig" rid="F1">Fig 1A</xref>). The presence of glucose in a strain lacking aPBPs increases the expression of LtaS and YfnI and these result in altered LTA production. Crucially, we identify a new role for MprF in altering LTA polymerisation in <italic>B. subtilis</italic> and <italic>S. aureus</italic>. Our results reveal that MprF acts to change the cell envelope in a more dramatic way than simply increasing the positive charge on the cell membrane which has implications for understanding the association of MprF with both virulence and antibiotic resistance in Gram-positive bacteria.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>MprF alters cell viability in absence of <italic>ponA</italic> or <italic>mbl</italic></title><p id="P7">In <italic>Bacillus subtilis</italic>, the absence of all aPBPs (<italic>Δ4</italic> for <italic>ΔponA ΔpbpD ΔpbpF ΔpbpG</italic> mutant) is conditionally lethal on glucose-rich PAB agar medium unless supplemented with magnesium (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R12">12</xref>, <xref ref-type="bibr" rid="R38">38</xref>). The suppressive effect of divalent magnesium has been observed in other cell-wall deficient mutants (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R38">38</xref>, <xref ref-type="bibr" rid="R39">39</xref>) and it is not well understood. To identify the cell wall factors able to suppress <italic>Δ4</italic> lethality, we applied a random transposition mutagenesis to a strain deleted for the vegetative aPBPs (<xref ref-type="table" rid="T1">Tables 1</xref>-<xref ref-type="table" rid="T3">3</xref>). Mapping of the transposon in strain SWA11a revealed an insertion in the gene <italic>mprF</italic>, encoding a lysyl-phosphatidylglycerol (LysPGol) synthase known to participate in phospholipid metabolism (<xref ref-type="fig" rid="F1">Fig 1</xref>) (<xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R28">28</xref>). Introduction of a <italic>mprF</italic> deletion into <italic>Δ4</italic>, confirmed that <italic>Δ4 ΔmprF</italic> was viable on nutrient agar (NA) with glucose and on PAB agar (<xref ref-type="fig" rid="F2">Fig 2A</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S1A</xref>). A strain lacking <italic>ponA</italic> (encoding the major aPBP (PBP1) is viable but exhibits a growth phenotype that is suppressed by magnesium (<xref ref-type="fig" rid="F2">Fig 2A</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S1B</xref>). Here the deletion of <italic>mprF</italic> in <italic>ΔponA</italic> improved its growth and its colony morphology.</p><p id="P8">In the light of these results we reasoned that if MprF activity is detrimental to <italic>Δ4</italic> its overexpression should be deleterious to <italic>ΔponA</italic>. Consistent with this, the overexpression of MprF (MprF ↑) was found to be lethal in <italic>ponA-</italic>deleted strains on NA-glucose (<xref ref-type="fig" rid="F2">Fig 2B</xref>). In contrast, on NA, both <italic>ΔponA</italic> and <italic>Δ4</italic> strains grew slowly when <italic>mprF</italic> overexpression was induced (<xref ref-type="fig" rid="F2">Fig 2B</xref>) but no obvious effect was observed for 168CA or <italic>Δ3</italic> aPBPs (<italic>ΔpbpD ΔpbpF ΔpbpG</italic>). We also observed that the overexpression of <italic>mprF</italic> caused the cells of <italic>ΔponA</italic> and <italic>Δ4</italic> to lyse in nutrient broth (NB) (<xref ref-type="supplementary-material" rid="SD1">Fig S1C</xref>).</p><p id="P9">The identification of <italic>ΔmprF</italic> as a suppressor suggested that increased negative charge on the membrane could contribute to the rescue of <italic>Δ4</italic> growth. This seemed to contradict the long-standing hypothetical role of magnesium in altering the cell envelope by neutralizing anionic polymers and/or autolysis activity (<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R5">5</xref>). As it is known that the function of <italic>dlt</italic> operon is to add positive charge to LTA, it would be predicted that the loss of Dlt’s function should have a similar effect as <italic>ΔmprF</italic> on <italic>Δ4</italic> strain viability (<xref ref-type="bibr" rid="R40">40</xref>, <xref ref-type="bibr" rid="R41">41</xref>). However, <italic>Δ4 ΔdltAB</italic> strain was unable to grow on glucose rich media (data not shown). We also deleted the genes encoding the cardiolipin synthases in <italic>Δ4</italic> to alter the membrane charge and the cellular pool of PGol (<xref ref-type="fig" rid="F1">Fig 1B</xref>) but the loss of cardiolipin had no suppressive effect on the <italic>Δ4</italic> phenotype (data not shown).</p><p id="P10">To understand if the effect of MprF was specific to <italic>Δ4</italic>, we altered MprF expression in other known magnesium dependent mutants <italic>ΔmreB</italic> and <italic>Δmbl</italic>. It should however be noted that only <italic>Δmbl</italic> requires magnesium to grow on plate compared to <italic>ΔmreB</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig S2A</xref>). MreB, Mbl and MreBH are actin-like isologues which help maintain cell shape by controlling both cell wall synthesis (<xref ref-type="bibr" rid="R42">42</xref>) and the major autolytic enzymes CwlO and LytE (Mbl for CwlO and MreB/BH for LytE) (<xref ref-type="bibr" rid="R43">43</xref>). Interestingly, we identified that MprF overexpression rescued the growth of <italic>Δmbl</italic> on NA-glucose and NA (<xref ref-type="fig" rid="F2">Fig 2B</xref>). In addition, the morphological defects associated with this mutation (<xref ref-type="bibr" rid="R16">16</xref>) were less pronounced, resulting in wide rod-like shape cells and cell chains that were less often twisted (<xref ref-type="fig" rid="F2">Fig 2C</xref>).</p><p id="P11">To explain our genetic findings in <italic>Δmbl</italic> background, we had to consider that MprF might play a role in cell wall metabolism. This idea seemed to be supported by transmission electron microscopy (TEM) of a strain overexpressing MprF (<xref ref-type="fig" rid="F2">Fig 2FG</xref>). Here cells exhibited an increase in cell wall thickness (it was also observed that cell poles were ‘dented’, and septa were misplaced), a defect similar to that observed in cell division mutants. However the change in cell morphology of the strain deleted for <italic>mprF</italic> was less significant (<xref ref-type="fig" rid="F2">Fig 2E</xref>).</p><p id="P12">Previous reports showed that lethality of <italic>B. subtilis</italic> Δ<italic>mbl</italic> is suppressed by the deletion of the major LTA-synthase LtaS (<xref ref-type="bibr" rid="R16">16</xref>) and other work had shown that in <italic>ltaS</italic> mutant the activity of the LTA-synthase YfnI results in longer LTA polymers (<xref ref-type="bibr" rid="R18">18</xref>). This suggested that the overexpression of MprF in Δ<italic>mbl</italic> might diminish the cellular level of PGol (through a different pathway, <xref ref-type="fig" rid="F1">Fig 1B</xref>) (<xref ref-type="bibr" rid="R24">24</xref>) or MprF might function in LTA synthesis.</p></sec><sec id="S4"><title>Conditional essentiality of UgtP in the absence of MprF and the Class A PBPs</title><p id="P13">To comprehend the effect of MprF-loss in a strain lacking aPBPs and identify the MprF suppression pathway, we carried out a transposon screen in a strain lacking the vegetative class A PBPs, <italic>mprF, lacA</italic> and carrying pLOSS-<italic>P<sub>spac</sub></italic>-<italic>ponA</italic> (strain AG200, <xref ref-type="table" rid="T1">Tables 1</xref>-<xref ref-type="table" rid="T2">2</xref>) (<xref ref-type="bibr" rid="R12">12</xref>) with the objective of identifying alleles that rendered the maintenance of the plasmid copy of <italic>ponA</italic> essential. From this screen strain AG200BK#42 was isolated with the expected phenotype and found to carry a transposon inserted in the gene <italic>gtaB</italic>. GtaB catalyses a cytoplasmic conversion of Glucose-1-P to UDP-Glc (<xref ref-type="fig" rid="F1">Fig 1</xref>), where the latter ultimately contributes to LTA synthesis and WTA modification. Subsequent mutagenesis in backgrounds <italic>Δ4</italic> and <italic>Δ4 ΔmprF</italic> confirmed the lethal (NA-glucose) and sick (NA) phenotypes in absence of GtaB (<xref ref-type="fig" rid="F3">Fig 3A</xref>).</p><p id="P14">To determine if this was related to LTA synthesis or WTA modification, we deleted sequentially, in the <italic>Δ4</italic> or <italic>Δ4</italic> pLOSS-<italic>P<sub>spac</sub></italic>-<italic>ponA</italic> backgrounds, each enzyme whose function is immediately upstream or downstream of GtaB (<xref ref-type="fig" rid="F1">Fig 1B</xref>). Characterisation of the resulting strains (<xref ref-type="table" rid="T2">Table 2</xref>) showed that only deletion of <italic>ugtP</italic>, the enzyme which produces the Glc<sub>2</sub>DAG lipid anchor for LTA, had a similar effect to that of <italic>gtaB</italic>. Strain <italic>Δ4 ΔmprF ΔugtP</italic> was unable to grow on NA glucose (<xref ref-type="fig" rid="F3">Fig 3A</xref>), a phenotype common to <italic>ΔponA ΔgtaB</italic> and <italic>ΔponA ΔugtP</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig S2C</xref>). On NA, <italic>Δ4 ΔgtaB</italic> and <italic>Δ4 ΔugtP</italic> grew very slowly (<xref ref-type="fig" rid="F3">Fig 3A</xref>, right panel).</p><p id="P15">LysPGol content increases in <italic>ΔugtP</italic> cells (<xref ref-type="bibr" rid="R24">24</xref>) which could explain the similarity of phenotype of <italic>Δ4 ΔugtP</italic> and <italic>Δ4</italic> MprF ↑ (i.e. slow growing on NA) but not the dominant effect of <italic>ΔugtP</italic> on <italic>Δ4 ΔmprF.</italic> In <italic>S. aureus</italic>, it has been observed that <italic>ΔugtP</italic> (<italic>ypfP</italic>) and <italic>ΔgtaB</italic> mutants produce long LTA (<xref ref-type="bibr" rid="R32">32</xref>). Thus this context and our results reinforced the idea that MprF may have a role in LTA synthesis.</p></sec><sec id="S5"><title>Growth of a strain lacking all aPBPs mutant improves in absence of LtaS</title><p id="P16">To verify that LTA synthesis alters <italic>Δ4</italic> growth, we analysed the phenotype of strains lacking aPBPs and the LTA-synthase genes individually or in combination (<xref ref-type="fig" rid="F1">Fig 1</xref>). Surprisingly, the <italic>Δ4 ΔltaS</italic> mutant was viable on NA-glucose as well as with the additional deletion of <italic>yfnI</italic> or <italic>yqgS</italic> (<xref ref-type="fig" rid="F3">Fig 3B</xref>). Other strains expressing LtaS showed limited growth and were found to pick up suppressor mutations rapidly on glucose (e.g. <italic>Δ4 ΔyfnI, Δ4 ΔyfnI ΔyqgS</italic>, <xref ref-type="fig" rid="F3">Fig 3B</xref>). Thus, LtaS activity is also linked to the glucose-associated lethality of <italic>Δ4</italic>. Interestingly, the absence of MprF is more advantageous to <italic>Δ4</italic>, as it results in a faster growth and larger colonies formed on NA-glucose compared to <italic>Δ4 ΔltaS</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig S1B</xref>). This phenotypic difference indicated that slightly different mechanisms helped restore the growth of <italic>Δ4</italic>.</p><p id="P17">To test this, LTA-synthase genes were systematically deleted in the <italic>Δ4 ΔmprF</italic> (AG223) background and the viability of the strains generated determined on NA with or without glucose. All the strains remained viable on NA glucose (<xref ref-type="fig" rid="F3">Fig 3C</xref>) which indicated the effect of MprF loss could be related to LTA. In support of this, in the <italic>Δ4 ΔmprF</italic> background the combined absence of <italic>ltaS</italic> and <italic>yfnI</italic> delayed growth on NA glucose resulting in a phenotype similar to that observed on NA (<xref ref-type="fig" rid="F3">Fig 3C</xref>). Thus, in these specific genetic backgrounds LTA synthesis is not essential but permitted higher growth efficiency.</p><p id="P18">Neither the absence of LtaS nor MprF had any effect on the filamentous thin cell morphology of <italic>Δ4</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig S3A-B</xref>, <xref ref-type="table" rid="T4">Table 4</xref>) but cell lysis was significantly decreased in NB. In the absence of all LTA-synthases, <italic>Bacillus</italic> is viable but the strain forms filamentous and clumpy cells (<xref ref-type="bibr" rid="R16">16</xref>). We observed that the combined absence of LtaS, YfnI and/or YqgS in <italic>Δ4, ΔponA</italic> or <italic>Δ4 ΔmprF</italic> genetic backgrounds lead to an increase in cell diameter and cells remained linked together at the site of division (<xref ref-type="fig" rid="F3">Fig 3D</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S3A-B</xref>, <xref ref-type="table" rid="T4">Table 4</xref>). However, when LtaS was the only functional LTA-synthase (e.g. <italic>Δ4 ΔyqgS ΔyfnI</italic>, <xref ref-type="fig" rid="F3">Fig 3D</xref>), cells were thin and comparable to <italic>Δ4</italic> and the <italic>ΔponA</italic> background (<xref ref-type="supplementary-material" rid="SD1">Fig S3C-D</xref>). Collectively, our results indicate that the activity of the LTA synthases, in particular LtaS activity, could account for <italic>Δ4</italic> phenotype.</p></sec><sec id="S6"><title>Impact of glucose, PBP1 and MprF on LTA synthesis</title><p id="P19">To comprehend the effect of LtaS, MprF and UgtP in the absence of aPBPs we decided to analyse LTA production. We developed a Western blot protocol relying on a monoclonal antibody for Gram-positive LTA (Thermofischer) and a polyclonal PBP2B antibody. First, we determined the LTA profile for 168CA and the LTA-synthases mutants (<xref ref-type="fig" rid="F4">Fig 4A</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig S4</xref>) grown in NB and NB glucose (0.2%). The wild type LTA signal corresponded to a mobility comparable to 7-17 kDa as previously identified (<xref ref-type="bibr" rid="R18">18</xref>). Interestingly, our media comparison showed that LTA-signal in <italic>ΔltaS</italic> cells grown in NB-glucose (&gt; 15 kDa) (<xref ref-type="fig" rid="F4">Fig 4A</xref> left panel, 2<sup>nd</sup> lane) was distinct from that seen for growth in NB (7-32 kDa) (<xref ref-type="fig" rid="F4">Fig 4A</xref> right panel, 2<sup>nd</sup> lane). However, the LTA pattern was different when YfnI was the only functional LTA-synthase (<xref ref-type="fig" rid="F4">Fig 4A</xref>). From this analysis, short LTA (&lt;10 kDa) were more abundantly produced in NB-glucose. This seemed to be related to LtaS activity, as we observed an increase in short LTA in <italic>ΔyfnI</italic> and <italic>ΔyfnI ΔyqgS</italic> mutants compared to 168CA (<xref ref-type="fig" rid="F4">Fig 4A</xref> left panel, 3<sup>rd</sup> &amp; 5<sup>th</sup> lanes). Collectively, our results show that the regulation of LTA synthesis is more complex than thought (<xref ref-type="bibr" rid="R18">18</xref>) as it influenced by the metabolic/nutritional status of the cells.</p><p id="P20">As the <italic>mprF</italic> mutation suppressed the <italic>ΔponA</italic> phenotype (<xref ref-type="fig" rid="F2">Fig 2A</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S1B</xref>) we reasoned that any alteration of LTA synthesis would be detectable in a strain where only the major aPBP was deleted. As the multiple aPBP deletion strain was very lytic and did not grow under certain conditions (<xref ref-type="supplementary-material" rid="SD1">Fig S1</xref>), further experiments were done in the <italic>ΔponA</italic> background. Using this background, strains could grow in NB glucose 0.2% and this permitted the preparation of samples for the Western blot analysis. Analysis of <italic>ΔponA</italic> cells grown in the presence of glucose revealed that there was an increase in short LTA that was not evident in the absence of glucose (<xref ref-type="fig" rid="F4">Fig 4B</xref> left panel, 3<sup>rd</sup> lane, <xref ref-type="supplementary-material" rid="SD1">Fig S5D</xref>). In comparison, the LTA signal of <italic>ΔponA ΔmprF</italic> decreased compared to <italic>ΔponA</italic> (<xref ref-type="fig" rid="F4">Fig 4B</xref> left panel, 5<sup>th</sup> lane) and the <italic>ΔmprF</italic> mutant in NB-glucose (<xref ref-type="fig" rid="F4">Fig 4B</xref> left panel, 4<sup>th</sup> lane) decreased compared to that of 168CA (<xref ref-type="supplementary-material" rid="SD1">Fig S5D</xref>). Surprisingly, we found that <italic>mprF</italic> overexpression (MprF ↑) had a significant effect, resulting in an increased LTA polymer length (6<sup>th</sup> lane in <xref ref-type="fig" rid="F4">Fig 4B</xref>). This effect was independent of YfnI, as a similar LTA profile was observed in a strain <italic>ΔyfnI</italic> MprF ↑ while the profile of a <italic>ΔltaS</italic> MprF ↑ was similar to that of <italic>ΔltaS</italic> (data not shown, strains AG353 &amp; AG349 in <xref ref-type="table" rid="T2">Table 2</xref>). The latter was expected as LtaS activity seems dominant over YfnI (<xref ref-type="bibr" rid="R18">18</xref>). The overexpression of <italic>mprF</italic> in <italic>ΔponA</italic> cells resulted in a broader size range of LTA than that seen for the wild type as we observed an increase in LTA signals below 10 kDa but also above 15 kDa (7<sup>th</sup> lane in <xref ref-type="fig" rid="F4">Fig 4B</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S5D</xref>). This to some extent resembled that observed in single mutants <italic>ΔponA</italic> and MprF ↑, respectively. Thus, the cumulative effect of the mutations had led to an increase in LTA length range and could explain the lethality of the <italic>ΔponA</italic> MprF ↑ double mutant on NA-glucose-IPTG (<xref ref-type="fig" rid="F2">Fig 2B</xref>).</p><p id="P21">Western blot analysis of the LTA in the <italic>Δmbl</italic> background showed that it was weak, and representative of short LTA (second to last lane <xref ref-type="fig" rid="F4">Fig 4B</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S5D</xref>). Overexpression of <italic>mprF</italic> rescued <italic>Δmbl</italic> growth (<xref ref-type="fig" rid="F2">Fig 2B</xref>) and this overexpression resulted in an increased in LTA length and abundance in the <italic>mbl</italic> background (last lane <xref ref-type="fig" rid="F4">Fig 4B</xref>). This result was also consistent with what was observed for <italic>Δmbl ΔltaS</italic> with the detection of longer LTA polymers (data not shown) similar to that of <italic>ΔltaS</italic> (<xref ref-type="fig" rid="F4">Fig 4A</xref>). Thus an increase in LTA length seems to characterize the effect of these two <italic>Δmbl</italic> suppressor mutations.</p><p id="P22">Analysis of the suppressor <italic>ΔltaS ΔponA</italic> revealed the dominance of <italic>ltaS</italic> deletion, in that the LTA exhibited a retarded migration (3<sup>rd</sup> lanes in <xref ref-type="fig" rid="F4">Fig 4C</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S6</xref>), similar to that observed in <italic>ΔltaS</italic> (<xref ref-type="fig" rid="F4">Fig 4C</xref>). In absence of UgtP which produces a lipid anchor Glc<sub>2</sub>DAG (<xref ref-type="fig" rid="F1">Fig 1</xref>), we observed an increase in LTA length in both media conditions, but the shift was more distinct in glucose (&gt;12 kDa, left panel 4<sup>th</sup> lane in <xref ref-type="fig" rid="F4">Fig 4C</xref>). The latter is comparable to the LTA signal detected in the <italic>S. aureus ΔugtP</italic> mutant grown in TSB, a glucose rich medium (<xref ref-type="bibr" rid="R32">32</xref>). Analysis of <italic>ΔponA ΔugtP</italic>, which was conditionally lethal on NA-glucose (<xref ref-type="supplementary-material" rid="SD1">Fig S2C</xref>), revealed an increase of the LTA-signals and length (7-25 kDa, left panel 5<sup>th</sup> lane, <xref ref-type="fig" rid="F4">Fig 4C</xref>), a pattern reminiscent of that determined for <italic>ΔponA</italic> MprFh ↑ strain (left panel 7<sup>th</sup> lane in <xref ref-type="fig" rid="F4">Fig 4B</xref>), which was also lethal on NA-glucose (<xref ref-type="fig" rid="F2">Fig 2B</xref>).</p><p id="P23">To conclude we show the first evidence that MprF activity has a role in altering the length of LTA, through a LtaS-dependent mechanism and has an impact on cell wall metabolism. Our results also highlight that the conditions leading to the lethality of <italic>ponA</italic> are associated with an increase in the abundance and length of LTA.</p></sec><sec id="S7"><title>Overexpression of major autolysin LytE is lethal in absence of PBP1 or LtaS</title><p id="P24">Our results inferred that the conditional lethality of aPBPs mutant might be linked to an interplay between LTA length and autolysin activity. Autolysins or cell wall hydrolases help shape and recycle the peptidoglycan during cell elongation and division. <italic>B. subtilis</italic> expresses a large number of them but only the loss of both PG D,L-endopeptidases CwlO and LytE is lethal (<xref ref-type="bibr" rid="R13">13</xref>, <xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R44">44</xref>–<xref ref-type="bibr" rid="R46">46</xref>) (<xref ref-type="fig" rid="F1">Fig 1A</xref>). We focused on LytE because it is considered to be one of the key autolysins, it is secreted and thought to be anchored to the lateral cell wall and the septum in a way that is influenced by the teichoic acids (<xref ref-type="bibr" rid="R43">43</xref>). LytE abundance also increased in <italic>ΔltaS</italic> (<xref ref-type="bibr" rid="R47">47</xref>) and both LtaS and LytE affect colony development (<xref ref-type="bibr" rid="R48">48</xref>) and cell diameter (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R43">43</xref>). We reasoned that if an imbalance of LytE activity existed in the aPBPs mutants (<italic>Δ4</italic> and <italic>ΔponA</italic>) grown in glucose-rich medium, then a deliberate increase in LytE expression should exacerbate the strain phenotype, leading to cell death. Interestingly, <italic>lytE</italic> overexpression (by IPTG induction of a <italic>P<sub>hyspank</sub>-lytE</italic> allele) was found to be lethal in both <italic>Δ4</italic> and <italic>ΔponA</italic> backgrounds when grown on NA-glucose and it significantly delayed the growth of <italic>Δ4</italic> and <italic>ΔponA</italic> on NA but not that of <italic>Δ3 ponA+</italic> (<xref ref-type="fig" rid="F5">Fig 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S7A</xref>). This result confirmed that an imbalance in autolytic activity was detrimental to the cell that had lost PBP1. Importantly, the overexpression of <italic>lytE</italic> in the <italic>Δ4 ΔltaS, ΔponA ΔltaS</italic> and <italic>ΔltaS</italic> strains was lethal (<xref ref-type="fig" rid="F5">Fig 5A</xref>) while the growth of <italic>ΔponA ΔmprF</italic> was only slightly delayed. However, the overexpression of <italic>lytE</italic> in <italic>Δ4 ΔmprF</italic> severely perturbed its growth on glucose but the strain remained viable. In contrast, the control strain with only the <italic>ΔmprF</italic> mutation was unaffected by <italic>lytE</italic> overexpression.</p><p id="P25">This finding suggested that <italic>ΔponA ΔltaS</italic> and <italic>ΔponA ΔmprF</italic> mutants, which have distinct LTA length, were differently sensitive to LytE activity. Therefore, we examined the double LTA-synthase mutant backgrounds, here we found that only the strain expressing <italic>ltaS</italic> was viable when <italic>lytE</italic> was overexpressed (<xref ref-type="fig" rid="F5">Fig 5A</xref>, last strain). In these genetic backgrounds, the absence of <italic>mprF</italic> or <italic>ugtP</italic> had no effect (data not shown). Interestingly, <italic>ΔltaS</italic> LytE h was viable on NA (<xref ref-type="fig" rid="F5">Fig 5A</xref>, 8<sup>th</sup> strain) but not on NA-glucose while we previously identified that <italic>ΔltaS</italic> produces distinct LTA length on each of these media (<xref ref-type="fig" rid="F4">Fig 4A</xref>). Thus, it is clear that the activity of LtaS, is required for the cell to balance the effect of overexpression of <italic>lytE</italic>, presumably by producing a specific LTA length.</p><p id="P26">To comprehend the apparent tolerance of LtaS<sup>+</sup> and <italic>ΔmprF</italic> cells to LytE, we constructed an unstable replicon pLOSS-<italic>P<sub>spac</sub></italic>-<italic>lytE</italic> plasmid which expresses <italic>lytE</italic> at a level lower than <italic>P<sub>hyspank-</sub>lytE</italic> (<xref ref-type="table" rid="T1">Table 1</xref>). This plasmid in the <italic>ΔmprF</italic> strain was retained in all media conditions tested (AG1481 strain), including elevated magnesium. This was indicated by the fact that the colonies remained blue on IPTG XGal supplemented media (<xref ref-type="fig" rid="F5">Fig 5B</xref>) whereas other strains tested showed instability of the plasmid (e.g. 168CA, <italic>ΔponA, ΔponA ΔmprF</italic> and LTA-synthases mutants, <xref ref-type="table" rid="T2">Table 2</xref>) an indication that there was no selective advantage for the cells to maintain the plasmid. Thus this plasmid stability assay highlights that <italic>ΔmprF</italic> cells tolerate higher expression of <italic>lytE</italic> compared to the other background strains tested. At this stage, it is unclear if the <italic>ΔmprF</italic> strain’s tolerance for <italic>lytE</italic> overexpression is due to the loss of aaPGols or the production of shorter LTA or both.</p></sec><sec id="S8"><title>LTA influences LytE activity</title><p id="P27">The conditional lethality observed when overexpressing <italic>lytE</italic> prompted us to investigate the cellular levels of this autolytic enzyme in our strains. First, we engineered strains that could express a recombinant protein LytE-LEMGRSH<sub>12</sub>(using pMUTin-<italic>‘lytE-his</italic>, <xref ref-type="table" rid="T1">Table 1</xref>) and then analysed total lysates by Western blot using anti-histidine (for LytE) (<xref ref-type="fig" rid="F5">Fig 5C</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S7B</xref>) and an anti-LtaS antibody raised against LtaS (74 kDa) that cross reacts with YfnI (73 kDa) (<xref ref-type="fig" rid="F5">Fig 5D</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S8A</xref>). This showed that LytE and LtaS/YfnI accumulate in <italic>ΔponA</italic> cells, particularly when grown in presence of glucose (<xref ref-type="fig" rid="F5">Fig 5C-D</xref>). Using a set of strains that had either pMUTin-<italic>‘ltaS-his</italic> or pMUTin-<italic>‘yfnI-his</italic> integrated into the genome, we could confirm that both LtaS and YfnI are more abundant in <italic>ponA</italic> cells (<xref ref-type="supplementary-material" rid="SD1">Fig S8B</xref>, <xref ref-type="table" rid="T1">Tables 1</xref>-<xref ref-type="table" rid="T3">3</xref>).</p><p id="P28">In <italic>ΔponA ΔmprF</italic>, LytE and LtaS/YfnI protein levels were lower compared to <italic>ΔponA</italic> (<xref ref-type="fig" rid="F5">Fig 5C-D</xref>), but no obvious change was observed in the wild-type background (WT*) and <italic>ΔmprF</italic> strains. <italic>ΔltaS</italic> and <italic>ΔponA ΔltaS</italic> exhibited an increase in both LytE and YfnI when grown in NB-glucose, an effect more pronounced in the <italic>ΔponA ΔltaS</italic> mutant (<xref ref-type="fig" rid="F5">Fig 5C-D</xref>, left panel). In addition, comparative analysis of the set of LTA-synthase mutants (<xref ref-type="supplementary-material" rid="SD1">Fig S8C</xref>) revealed that LtaS/YfnI increased in presence of glucose and in the absence of YfnI, LtaS increased significantly. Also, and potentially more importantly, in the absence of LtaS, LytE abundance increased. Analyses of the strains that were lytic under the same growth conditions showed that there was an excess of LtaS/YfnI in <italic>ΔponA ΔugtP</italic> and <italic>ΔponA</italic> MprF ↑ cells cultured in either NB or NB-glucose (<xref ref-type="supplementary-material" rid="SD1">Fig S9B-C</xref>, e.g. 6-7<sup>th</sup> lanes). It was also evident that LytE was more abundant than the wild type. These observations seem to support the idea that the altered abundance of these proteins, identified in <italic>ΔponA</italic> cells, was associated with the sick phenotype.</p><p id="P29">Taken together, our results show a correlation between LTA length and LytE abundance in the cell which suggests that LTA acts to moderate cell wall metabolism. In <italic>ponA</italic> mutants, this function is unbalanced such that cell wall degradation is predominant. This is summarised in the discussion in <xref ref-type="fig" rid="F7">Fig 7</xref>.</p></sec><sec id="S9"><title>LTA production is altered in <italic>S. aureus ΔmprF</italic> and is an important factor in <italic>B. subtilis</italic> sensitivity to daptomycin</title><p id="P30">MprF is conserved in the <italic>Firmicutes</italic> and has been shown to contribute to <italic>S. aureus</italic> pathogenicity (<xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R22">22</xref>). Importantly, studies of clinical isolates have found that methicillin-resistant <italic>S. aureus</italic> strains (MRSA) that have acquired resistance to daptomycin (Dap<sup>R</sup>), a lipopeptide antibiotic that acts to interfere with membrane containing phosphatidylglycerol (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R49">49</xref>–<xref ref-type="bibr" rid="R51">51</xref>), frequently carry nucleotide polymorphisms (SNPs) in <italic>mprF</italic> (<xref ref-type="bibr" rid="R52">52</xref>, <xref ref-type="bibr" rid="R53">53</xref>). Although some <italic>mprF</italic> SNPs were associated with a MprF gain of activity (increasing LysPGol and reducing PGol), others had no clear correlation between the phospholipids composition and the relative surface charge of the cell (<xref ref-type="bibr" rid="R26">26</xref>). In this context, we asked whether the role of MprF in LTA production is conserved in <italic>S. aureus</italic> as it seemed reasonable that this might contribute to Dap resistance. Analysis of LTA production in methicillin sensitive <italic>S. aureus</italic> strains showed that the LTA from the <italic>mprF</italic> mutant migrated faster than that of the wild type SA113 (<xref ref-type="fig" rid="F6">Fig 6A</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S10A</xref>), thus LTA production is altered in <italic>S. aureus ΔmprF</italic>. Interestingly, when exposing exponentially growing cells of <italic>S. aureus</italic> to daptomycin, our analysis showed that the LTA length and production had increased in both strains (<xref ref-type="supplementary-material" rid="SD1">Fig. S10B-C</xref>, samples treated with 0.25 and 0.5 μg/ml DAP for <italic>ΔmprF</italic> and the wild type, respectively). It is also noteworthy that even when exposed to DAP, the LTA produced by the wild type remained longer than that of the <italic>ΔmprF</italic> mutant, which perhaps indicates that the LTA length plays a role in DAP sensitivity. This effect was observed at DAP concentrations that did not significantly impacted on the wild type growth (<xref ref-type="supplementary-material" rid="SD1">Fig. S10E</xref>) whereas the growth of the <italic>mprF</italic> mutant was significantly impaired (<xref ref-type="supplementary-material" rid="SD1">Fig. S10D-E</xref>), as previously reported (<xref ref-type="bibr" rid="R52">52</xref>, <xref ref-type="bibr" rid="R53">53</xref>). Our results seem to confirm that MprF’s role in modulating LTA production is conserved in both <italic>Bacillus</italic> and <italic>Staphylococcus</italic> species. Collectively, these results indicate that a change in LTA nature and/or production, rather than an alteration in membrane properties, might be associated with Dap resistance in <italic>S. aureus</italic>.</p><p id="P31">As we could not carry analysis on Dap<sup>R</sup> MRSA (laboratory regulations), we, therefore, turned our interest to the strongest known Dap<sup>R</sup> allele in <italic>B. subtilis, pgsA A64V</italic> (<xref ref-type="bibr" rid="R54">54</xref>). This mutation of the essential gene <italic>pgsA</italic>, encoding the PGol-synthase (<xref ref-type="fig" rid="F1">Fig 1B</xref>), has been shown to reduce cellular PGol content and was suggested to modify LTA production (<xref ref-type="bibr" rid="R54">54</xref>). Thus, we analysed the LTA of <italic>B. subtilis</italic> wild type (WT), isogenic strains carrying <italic>pgsA<sup>A64V</sup></italic> (strains Dap<sup>R</sup> 1 &amp; Dap<sup>R</sup> 20) and <italic>pgsA<sup>A64V</sup></italic> complemented with <italic>pgsA</italic><sup>WT</sup> grown overnight in NB (<xref ref-type="fig" rid="F6">Fig 6B</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S10F</xref>). Our assays revealed that no LTA signal was detected below 30 kDa in Dap<sup>R</sup> strains whereas LTA was detected in the strains complemented for <italic>pgsA</italic> (Dap<sup>R</sup> <italic>pgsA</italic><sup>WT</sup>) that were similar to that of the wild type strain. Thus, PgsA A64V accounts for the severe reduction in LTA production. Finally, we verified that the two major LTA-synthases were still produced in Dap<sup>R</sup> strains by Western blot (<xref ref-type="fig" rid="F6">Fig 6B</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S10F</xref>). A strong LtaS/YfnI signal was detected in Dap<sup>R</sup> strains which proved that one or both LTA-synthases were still expressed, but up-regulated.</p><p id="P32">The above findings in <italic>S. aureus</italic> and <italic>B. subtilis</italic> suggested that alteration in LTA could be associated with DAP sensitivity. As <italic>S. aureus ltaS</italic> is essential, we decided to analyse the Dap-sensitivity of <italic>B. subtilis</italic> expressing only one LTA-synthase. Our assays on NA (<xref ref-type="fig" rid="F6">Fig 6C</xref>) and NB (<xref ref-type="supplementary-material" rid="SD1">Fig. S10G</xref>) showed that strains lacking the major LTA-synthase LtaS were sensitive to DAP and this sensitivity was higher than that observed for <italic>ΔmprF</italic> or <italic>Δdlt</italic> mutants (<xref ref-type="supplementary-material" rid="SD1">Fig S10G</xref>). Thus LtaS activity is required for DAP tolerance in <italic>B. subtilis</italic>, more so than MprF.</p></sec></sec><sec id="S10" sec-type="discussion"><title>Discussion</title><p id="P33">In absence of the class A PBPs (Δ4), <italic>B. subtilis</italic> is viable due to the presence of RodA, the essential PG glycosyltransferase (controlled at least in part by the cell envelope stress regulator σ<sup>M</sup> (<xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R12">12</xref>)) and yet lethal on glucose rich medium (<xref ref-type="fig" rid="F2">Fig 2A</xref> &amp; <xref ref-type="supplementary-material" rid="SD1">S1B</xref>). By studying either <italic>Δ4</italic> or <italic>ΔponA</italic> single mutant, we now understand that the presence of glucose leads to an increase in abundance of the LTA-synthases LtaS and YfnI. The increase in these enzymes results in altered LTA production that in turn causes the accumulation of major autolysin LytE (<xref ref-type="fig" rid="F4">Fig 4</xref>-<xref ref-type="fig" rid="F5">5</xref>), the end result being cell lysis through the inability to regulate the activity of autolysins (<xref ref-type="fig" rid="F7">Fig 7</xref>). This lytic phenotype could be suppressed by the absence of MprF (<xref ref-type="fig" rid="F2">Fig 2A</xref>, <xref ref-type="supplementary-material" rid="SD1">S1B</xref>), an enzyme that we think helps in the regulation of LTA production (<xref ref-type="fig" rid="F8">Fig 8</xref>). In <italic>ΔponA</italic>, loss of MprF resulted in reduced LTA production and decreased level of LytE (<xref ref-type="fig" rid="F4">Fig 4B</xref>, <xref ref-type="fig" rid="F5">5C</xref>, <xref ref-type="supplementary-material" rid="SD1">S5D</xref>). This was consistent with our finding that an increase in length and abundance of LTA (overexpression <italic>mprF, ΔugtP</italic>) and/or an increase in LytE correlated with glucose-mediated lethality in <italic>ΔponA</italic> (<xref ref-type="fig" rid="F2">Fig 2B</xref>, <xref ref-type="fig" rid="F3">3A</xref>, <xref ref-type="fig" rid="F4">4B-C</xref>, <xref ref-type="fig" rid="F5">5A</xref>, <xref ref-type="supplementary-material" rid="SD1">S5D</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S9B-C</xref>). Loss of major LTA-synthase LtaS was not as beneficial for the growth of <italic>Δ4</italic> as the loss of MprF (<xref ref-type="fig" rid="F3">Fig 3B</xref>, <xref ref-type="supplementary-material" rid="SD1">S1B</xref>). In <italic>ΔponA</italic>, loss of LtaS lead to the production of very long LTA polymers similar to the single <italic>ltaS</italic> mutant and a persisting high level of LytE (<xref ref-type="fig" rid="F4">Fig 4C</xref>, <xref ref-type="fig" rid="F5">5C</xref>). This might explain why the growth of <italic>ΔponA ΔltaS</italic> was not significantly enhanced compared to <italic>ΔponA</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig S1B</xref>). In support of this, the analysis of strains only defective in LTA synthesis (last three rows in <xref ref-type="fig" rid="F5">Fig 5A</xref>) indicated that LtaS presence is required to prevent cell lysis when <italic>lytE</italic> was artificial overexpressed (<xref ref-type="fig" rid="F5">Fig 5A</xref>, <xref ref-type="fig" rid="F7">7</xref>), presumably because a distinct LTA length (7-17kDa) and/or abundance similar to the wild type LTA (<xref ref-type="fig" rid="F4">Fig 4A</xref>) is required (<xref ref-type="fig" rid="F7">Fig 7</xref>).</p><p id="P34">Previous studies have suggested that LTA could inhibit autolysins activity (<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R5">5</xref>) but the key factors involved have not been identified. Recent work in <italic>S. aureus</italic> showed a <italic>ΔugtP</italic> mutant producing long LTA is susceptible to PG hydrolases (<xref ref-type="bibr" rid="R55">55</xref>) and it has been suggested that major autolysin LytA is sequestered by LTA in exponential growth (<xref ref-type="bibr" rid="R56">56</xref>). Our results indicate that LytE in <italic>B. subtilis</italic> exhibits similar characteristics and that the length of LTA has a role in modulating LytE abundance or presumably its activity (<xref ref-type="fig" rid="F7">Fig 7</xref>). However it is unclear how this mechanism may work in relation to the localisation of the LTA in the wall relative to active autolysins, particularly LytE, and this remains an important question to answer in future work.</p><p id="P35">In <italic>B. subtilis</italic> 168, expression of <italic>lytE</italic> is quite complex and coordinated by regulators such as σ<sup>I</sup> and WalR (<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R57">57</xref>). In contrast, transcriptional regulation of <italic>mprF</italic> is not well defined, but interestingly analysis of <italic>B. subtilis</italic> BSB1 showed that <italic>mprF</italic> and <italic>pgsA</italic> expression is positively correlated with that of <italic>walKR</italic>, the two-component response system that controls cell wall metabolism, and notably <italic>lytE</italic> (cluster A418 in Subtiwiki expression data browser; (<xref ref-type="bibr" rid="R58">58</xref>, <xref ref-type="bibr" rid="R59">59</xref>)). However, expression of <italic>walKR</italic> and <italic>sigI</italic> is not significantly altered in LB-glucose (<xref ref-type="bibr" rid="R58">58</xref>) or in the absence of aPBPs (<xref ref-type="bibr" rid="R12">12</xref>) but theses regulators might play a post-transcriptional role in <italic>Δ4</italic> where the σ<sup>M</sup> cell wall stress response is active (<xref ref-type="bibr" rid="R12">12</xref>, <xref ref-type="bibr" rid="R57">57</xref>). This seems to be supported by the fact that some of the cell wall associated genes mentioned (<italic>sigM, ponA, ltaS, yfnI, mprF, pgsA</italic>) are differently expressed in cells of <italic>B. subtilis</italic> BSB1 in LB-glucose (<xref ref-type="bibr" rid="R58">58</xref>, <xref ref-type="bibr" rid="R59">59</xref>). Thus <italic>B. subtilis</italic> might need to adapt its cell wall metabolism in response to glucose and this might account for the partial redundancy of function of <italic>B. subtilis</italic> LTA-synthases. Evidence also suggest that the presence of magnesium in culture medium leads <italic>Bacillus</italic> cells to adjust its cell wall metabolism. When we looked at the effect of magnesium in presence of glucose on aPBP mutants, as this is known to suppress the growth defect (<xref ref-type="bibr" rid="R10">10</xref>), we have observed that magnesium decreased the abundance of LytE significantly in <italic>ΔponA</italic> and <italic>ΔponA ΔmprF</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig S9</xref>) but not as much in <italic>ΔponA ΔltaS</italic>. In addition, high levels of magnesium have an impact on LTA production (work in progress) and other processes (<xref ref-type="bibr" rid="R60">60</xref>, <xref ref-type="bibr" rid="R61">61</xref>). Thus, the mechanism by which exogenous magnesium helps the growth of some cell wall mutants might partially require LtaS activity to tune LytE abundance in the cell wall (<xref ref-type="bibr" rid="R14">14</xref>). Altogether, our study brings a new perspective on the importance of LTA in the cell envelope stability and how the extracellular biosynthesis is regulated.</p><p id="P36">In this study, we have identified a new function for MprF, an enzyme known to synthetise aminoacyl-phosphatidylglycerol (aaPGol) phospholipids and translocate them across the membrane (<xref ref-type="fig" rid="F1">Fig 1</xref>). We show that MprF activity impacts the biosynthesis of LTA (<xref ref-type="fig" rid="F8">Fig 8A</xref>) and this in turn alters cell wall metabolism. The LTA profiles observed in <italic>B. subtilis</italic> and <italic>S. aureus</italic> lacking MprF (seen as shorter and/or decreased in abundance) and the overexpression of <italic>B. subtilis</italic> MprF (causing a smeared &amp; retarded mobility of the LTA) (<xref ref-type="fig" rid="F4">Fig 4B</xref>, <xref ref-type="fig" rid="F6">6A</xref>) suggest that MprF positively regulates LTA production (<xref ref-type="fig" rid="F8">Fig 8A</xref>). Other studies have indicated that MprFs may have relaxed substrate specificities across species (<xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="bibr" rid="R62">62</xref>) and even synthetise lysyl-glucosyl-DAG glycolipid in <italic>Streptococcus agalactiae</italic> (<xref ref-type="bibr" rid="R63">63</xref>). Recently, it has been shown that when <italic>S. aureus</italic> LtaS uses PGol as an alternative anchor to the glycolipid produced by UgtP, the concentration of these free lipid starter units regulates the length of the LTA polymerised <italic>in vitro</italic> (<xref ref-type="bibr" rid="R33">33</xref>). Thus it is possible that MprF activity contributes to LTA synthesis (<xref ref-type="fig" rid="F8">Fig 8B</xref>). MprF might provide the last capping unit (Lys-, Ala-GroP) to LtaS to terminate the LTA being polymerised, this would also contribute to the protection against CAMPs (<xref ref-type="fig" rid="F8">Fig 8B</xref>). Alternatively, aaPGols might be a source of GroP units (<xref ref-type="fig" rid="F8">Fig 8B</xref>) in the formation of LTA in addition to the known PGol source altering processivity (<xref ref-type="bibr" rid="R33">33</xref>). Another possibility would be that aaPGols change the electrostatic environment and this impacts on LTA-synthase(s) activity by keeping the LTA polymers adjacent to the membrane (<xref ref-type="fig" rid="F8">Fig 8B</xref>).</p><p id="P37">Gain of function in MprF has been identified in methicillin-resistant <italic>S. aureus</italic> (MRSA) clinical isolates that have acquired resistance to daptomycin (Dap), an antibiotic used as a last resort to treat MRSA infections (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R53">53</xref>). Over the years, MprF-mediated resistance to Dap (Dap<sup>R</sup>) has been investigated but a consensus model has yet to link Dap<sup>R</sup> to a particular domain of MprF and/or to a particular LysPGol content in one or both membrane leaflets (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R64">64</xref>). In <italic>B. subtilis</italic>, our analysis shows the significant decrease of LTA produced in a strain with the <italic>pgsA A64V</italic> mutation (<xref ref-type="fig" rid="F6">Fig 6B</xref>), a strain with a reduced PGol content that exhibits Dap resistance (<xref ref-type="bibr" rid="R54">54</xref>). Also, we found that LTA-synthase LtaS is required for DAP tolerance in <italic>B. subtilis</italic> (<xref ref-type="fig" rid="F6">Fig 6C</xref>). The function of MprF in LTA synthesis and the new understanding of <italic>S. aureus</italic> LtaS processivity (<xref ref-type="bibr" rid="R33">33</xref>) could be the link with the alleles <italic>cls</italic> encoding a cardiolipin synthase, <italic>pgsA</italic> and <italic>dlt</italic> operon (<xref ref-type="bibr" rid="R50">50</xref>) identified in <italic>S. aureus</italic> MRSA that result in Dap resistance. Together, these findings support the idea that a modification in LTA polymerisation in addition to D-alanylation of teichoic acid (<xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R66">66</xref>) could result in a cell envelope that is less permeable to Dap, and not necessarily linked to increased cell wall thickness (<xref ref-type="bibr" rid="R67">67</xref>). Further analysis of LTA synthesis and cell wall composition will help redefine MprF-mediated Dap<sup>R</sup> mechanism and help appreciate the exact role of MprF in the net cell surface charge and the protection against cationic antimicrobial peptides. Recent research on compounds targeting LTA synthesis (<xref ref-type="bibr" rid="R68">68</xref>, <xref ref-type="bibr" rid="R69">69</xref>) and on MprF-targeting monoclonal antibodies (<xref ref-type="bibr" rid="R70">70</xref>) suggest these approaches have relevance in combating clinically relevant bacteria.</p></sec><sec id="S11" sec-type="materials | methods"><title>Material and Methods</title><sec id="S12"><title>Plasmids, bacterial strains, and primers</title><p id="P38">Plasmids and strains used in this study are listed in <xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>. Strains constructions are described below or in <xref ref-type="table" rid="T2">Table 2</xref> (last column). Primers used are listed in <xref ref-type="table" rid="T3">Table 3</xref>.</p></sec><sec id="S13"><title>Growth conditions and general methods</title><p id="P39"><italic>B. subtilis</italic> strains were grown routinely on nutrient agar (NA, Oxoid) or in nutrient broth (NB, Oxoid). For some assays, strains were grown in liquid Difco antibiotic medium 3 (PAB, Oxoid) and PAB agar (15 g/l agar, Oxoid). <italic>B. subtilis</italic> transformations were carried out as previously described using SMM defined minimal medium (<xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref>). <italic>B. subtilis</italic> was usually incubated at 30°C (overnight), next day cells were diluted and grown at 37°C (unless specified differently). <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic> strains were incubated at 37°C on NA plate or in Luria-Bertani (LB). PCR, plasmid manipulations, and <italic>E. coli</italic> transformation were carried out using standard methods. Strains were selected on NA supplemented with ampicillin (for <italic>E. coli</italic>, 200 μg/ml), spectinomycin (60 μg/ml), kanamycin (5 μg/ml), phleomycin (1 μg/ml), erythromycin (0.5 μg/ml), chloramphenicol (5 μg/ml) and daptomycin (see later). Various supplements were also used: IPTG (isopropyl-β-D-thiogalactopyranoside, 0.1 or 1 mM), X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside, 100 μg/ml), MgS0<sub>4</sub> (between 5 mM to 25 mM as required), and glucose (final concentrations up to 1%). For NA plates supplemented with 20 mM MgSO<sub>4</sub>, the concentration of spectinomycin, kanamycin and erythromycin antibiotics was doubled to avoid growth of false positive strains. Strains with the pMUTin-<italic>his</italic> integration were always grown in presence of erythromycin.</p></sec><sec id="S14"><title>Plasmids constructions</title><p id="P40">To obtain pDR111<italic>-P<sub>hyspank</sub>-mprF</italic> plasmid, the <italic>mprF</italic> (BSU_08425) coding sequence was amplified using primers oAG271-272, which changed the start codon (from TTG to ATG). The PCR product and pDR111 plasmid (<xref ref-type="table" rid="T1">Table 1</xref>) were digested by <italic>Sal</italic>I and <italic>Sph</italic>I restriction enzymes, ligated together and transformed into <italic>E. coli</italic> DH5α. Digestion and PCR sequencing using primers oAG300-301 verified the presence of the insert.</p><p id="P41">To construct pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>ltaS</italic>, pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>yfnI</italic> and pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>yqgS</italic>, each LTA-synthase gene was amplified by PCR with primers pairs oAG308-309 (2064 bp), oAG310-311 (2078 bp) and oAG312-313 (1990 bp), respectively. PCR products were digested by <italic>Nhe</italic>I and <italic>Sph</italic>I, each ligated with the plasmid pDR111 digested with the same restriction enzymes. The next steps were carried out as described for pDR111<italic>-P<sub>hyspank</sub>-mprF</italic>.</p><p id="P42">For pLOSS-<italic>P<sub>spac</sub>-lytE, lytE</italic> was amplified by PCR with oAG348-349 (1143 bp) primers, and the PCR product inserted in pLOSS* (<xref ref-type="table" rid="T1">Table 1</xref>) as a <italic>Not</italic>I and <italic>Bam</italic>HI fragment. After transformation, the resulting plasmid was checked by PCRs with primers oAG18-19 and finally checked by sequencing.</p><p id="P43">To construct the plasmids pMUTin-<italic>‘lytE-his</italic>, pMUTin-<italic>‘ltaS-his</italic> and pMUTin-<italic>‘yfnI-his</italic> the 3’-terminus part of gene of interest gene (except for the stop codon) was amplified with primer pairs oAG354-355, oAG366-367 and oAG360-361, respectively to obtain a PCR products ranging from 288 to 309 bp. The PCR products and the plasmid pMUTinHis (<xref ref-type="table" rid="T1">Table 1</xref>) (<xref ref-type="bibr" rid="R73">73</xref>) were digested by <italic>Eco</italic>RI and <italic>Xho</italic>I, ligated together and transformed into <italic>E. coli</italic> DH5α. Each insertion ‘<italic>lytE, ‘ltaS</italic> and <italic>‘yfnI</italic> was verified by PCR and plasmid sequencing using primers oAG368-369. To construct pAM-21, plasmid pET28a (+) (Novagen) and <italic>lytE</italic> (from the 76<sup>th</sup> bp, removing the coding sequence for the signal peptide) were amplified by PCRs using primer pairs oAA01-02 and oAA03-04, respectively. DNA fragments generated were assembled using NEBuilder HiFi DNA assembly kit (NEB). The resulting plasmid was verified by sequencing using primers oAA05-06.</p></sec><sec id="S15"><title>Bacillus directed mutagenesis</title><p id="P44">Steps leading to construction of new mutants are indicated in the last column of <xref ref-type="table" rid="T2">Table 2</xref> with additional details in this section. New mutants were often obtained by transformation of competent cells with a clean genomic DNA extracted from another existing <italic>B. subtilis</italic> mutants. Construction of some of the markerless class A PBPs mutants were previously described (<xref ref-type="bibr" rid="R12">12</xref>). Additional mutants described in this study were obtained using the plasmids pG+host9::<italic>ΔponA</italic>, pG+host10::<italic>ΔpbpD</italic>, pG+host10::<italic>ΔpbpF</italic> (<xref ref-type="table" rid="T1">Table 1</xref>) (<xref ref-type="bibr" rid="R12">12</xref>). PCR with primers oAG124 to oAG129 were consistently performed to check markerless deletions were not lost (<xref ref-type="bibr" rid="R12">12</xref>).</p><p id="P45">All transformations of the background strain with, and/or leading to, deletion of <italic>ponA, mreB</italic>, <italic>mbl, gtaB, ugtP, ltaS</italic> were selected for on NA medium supplemented with MgSO<sub>4</sub>(20-25 mM) with the appropriate antibiotic.</p><p id="P46">To construct strain AG181 (<italic>ΔmprF</italic>), DNA fragments upstream and downstream the <italic>mprF</italic> coding sequence were amplified by PCR using primers oAG103-104 (2390 bp) and oAG105-106 (2414 bp), respectively and were digested by <italic>Eco</italic>RI and <italic>Xba</italic>I, respectively. The phleomycin resistance antibiotic cassette was amplified by PCR with primers PhleoXbaIfor and PhleoEcoRIrev from plasmid pIC22 and digested by both <italic>Eco</italic>RI and <italic>Xba</italic>I. The 3 digested PCR-fragments were ligated to generate a linear DNA, transformed into 168CA with selection for phleomycin resistance. The deletion of <italic>mprF</italic> was confirmed by PCR using primers oAG107-108.</p><p id="P47">Strain AG304 (<italic>amyE::P<sub>hyspank</sub>mprF, spc</italic>) was obtained by transformation of 168CA with pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>mprF</italic> plasmid (<xref ref-type="table" rid="T1">Table 1</xref>). Correct recombination was confirmed by the absence of amylase activity when grown on NA with 0.2% starch and by PCR (oAG300-301 primers). The same methods were used after transformation of other pDR111-derivatives. We constructed our own <italic>lytE</italic> deletion mutant (<italic>∆lytE::cat</italic>). For this, regions of genomic DNA upstream and downstream of <italic>lytE</italic> were amplified by PCRs with oAG350-351 (2048 bp) and oAG352-353 (2500 bp) primers pairs, respectively. These products were then digested by <italic>Xba</italic>I or <italic>Bam</italic>HI (<xref ref-type="table" rid="T3">Table 3</xref>). The chloramphenicol resistance cassette from pCotC-GFP plasmid (<xref ref-type="table" rid="T1">Table 1</xref>) was amplified with primers oAG197-198. The resulting PCR products (850 bp) was then digested by <italic>Xba</italic>I and <italic>Bam</italic>HI and the three DNA fragments were ligated and transformed into <italic>B. subtilis</italic> 168CA. Strain AG547 was obtained from this transformation and the deletion of <italic>lytE</italic> confirmed by PCR using primers oAG340-341 (<xref ref-type="table" rid="T3">Table 3</xref>).</p><p id="P48">Strains AG565 and AG586 were obtained by integration of pMUTin-‘<italic>lytE-his</italic> (erythromycin selection) in 168CA and <italic>∆cwlO</italic> (AG474 strain) background, respectively. The plasmid integration (single cross-over) in <italic>B. subtilis</italic> resulted in expression of recombinant proteins with LEMRGSH<sub>12</sub> tag in C-terminus, under the control of its native promoter. Since the integration of this plasmid into the <italic>∆cwlO</italic> background did not result in any phenotypic change it indicated that the LytE-His<sub>12</sub> was functional, as a double mutant <italic>lytE cwlO</italic> is lethal (<xref ref-type="bibr" rid="R44">44</xref>). Thereafter, genomic DNA of AG565 strain was used to transform all the strains needed for Western blot analysis (<xref ref-type="table" rid="T2">Table 2</xref>). Of note, AG1541 strain (<italic>ΔcwlO</italic>) obtained by genomic DNA recombination has the same genotype as AG586 strain obtained by plasmid integration.</p></sec><sec id="S16"><title>Random transposition mutageneses</title><p id="P49">Random transposition mutageneses were performed as previously described (<xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R74">74</xref>) using the pMarB plasmid that carries the transposon TnYLB-1 encoding kanamycin resistance. pMarB was introduced into <italic>B. subtilis</italic> strains carrying pLOSS-<italic>P<sub>spac</sub></italic>-<italic>ponA</italic> (<xref ref-type="bibr" rid="R12">12</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>), a plasmid with an unstable origin of replication and <italic>lacZ</italic> which helps to monitor the plasmid stability by observing formation of blue or white colonies. After screening the random library of mutants, genomic DNA extracted from positive clones were backcrossed into the parental strain used for the transposon screen. Transposon insertion sites were identified by inverse PCR using gDNA extracted from the backcrossed positive clones (<xref ref-type="bibr" rid="R74">74</xref>) and sequencing the resulting PCR products. Further verification of the transposon’s site of insertion was obtained using specific primers. For the suppressor screen in <italic>ponA pbpD pbpF</italic> mutant background, we constructed strain AG141 (<xref ref-type="table" rid="T2">Table 2</xref>) which carries deletions of the three vegetative class A PBPs, <italic>lacA</italic> gene (<xref ref-type="bibr" rid="R74">74</xref>) and pLOSS-<italic>P<sub>spac</sub></italic>-<italic>ponA</italic> (<xref ref-type="bibr" rid="R12">12</xref>). The transposon mutant library was screened on PAB agar supplemented with MgSO<sub>4</sub> (10 mM), X-Gal and IPTG (1 mM) and white colonies selected. The strain SWA11a (<xref ref-type="table" rid="T2">Table 2</xref>) had a transposon in <italic>mprF</italic> coding sequence which was verified using specific primers oAG81-82 (<xref ref-type="table" rid="T3">Table 3</xref>).</p><p id="P50">A conditional lethal screen was also carried out in a <italic>ponA pbpD pbpF mprF lacA</italic> pLOSS-<italic>P<sub>spac-</sub>ponA</italic> strain (AG200, <xref ref-type="table" rid="T2">Table 2</xref>). Here the transposon mutant library was screened on NA and PAB supplemented with X-Gal and IPTG (1mM). Blue colonies indicating plasmid stability were selected. One mutant was isolated and its genomic DNA was backcrossed into AG200 background. The resulting blue forming AG200BK#42 strain (<xref ref-type="table" rid="T2">Table 2</xref>) was found to carry a transposon in <italic>gtaB</italic>’s coding sequence using primers oAG165-166 (<xref ref-type="table" rid="T3">Table 3</xref>).</p></sec><sec id="S17"><title>Spot growth assays</title><p id="P51">Strains were grown in NB with 20 mM MgSO<sub>4</sub> at 30°C overnight. The cultures were then diluted 1:100 into fresh NB 10 mM MgSO<sub>4</sub> (or when applicable 20 mM) and grown up to mid exponential phase at 37°C. Cells were harvested, washed in NB, and diluted to an OD<sub>600nm</sub> ≈ 0.3 in NB. Each strain sample was then serially diluted 1:10 using a 96-multiwell plate and NB. Using a multichannel pipette, 5 μl of each dilution were transferred to various agar plates. As a control all the serial dilutions presented in the figures were also spotted on media supplemented with 10 mM or 20 mM MgS0<sub>4</sub> to ensure that growth occurred for all spots (data not shown). Plates were incubated at 37°C overnight and scanned at different time points. Images were edited in Photoshop CS software.</p></sec><sec id="S18"><title>Microscopic imaging</title><p id="P52">Cells were grown to exponential growth phase at 37 °C in NB medium. Before the cells were mounted onto microscopic slides, the slides were covered with a thin layer of NA medium supplemented with the FM5-95 membrane dye at 140 μg/ml (Invitrogen). Fluorescence microscopy was carried out with a Zeiss Axiovert 200M microscope attached to a Sony Cool-Snap HQ cooled CCD camera with Nikon APO x100/1.40 oil Ph3 objective lens. Images were acquired using Metamorph 6 imaging software (Molecular Devices, Inc). Images were analysed with ImageJ (<ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/">http://rsb.info.nih.gov/ij/</ext-link>) and assembled with Photoshop CS software.</p><p id="P53">Images stained with the FM5-95 membrane dye were processed using the plugin ObjectJ in ImageJ (<ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/">http://rsb.info.nih.gov/ij/</ext-link>) to measure cell diameter and cell length of about 400 cells per strain. Measurements were performed only once as cell diameter change was obvious under the microscope and on the images of <xref ref-type="fig" rid="F3">Fig 3D</xref> (details in <xref ref-type="supplementary-material" rid="SD1">Fig S3AB</xref>, <xref ref-type="table" rid="T4">Table 4</xref>).</p></sec><sec id="S19"><title>Transmission electron microscopy</title><p id="P54">Strains were grown in NB medium (with IPTG when applicable) until reaching an OD<sub>600nm</sub> of about 0.4. The cell pellets were fixed in 2% glutaraldehyde in sodium cacodylate buffer at 4°C for at least 24 h. Samples were spun and molten 4% agarose was added to the sample and re spun. Sample were allowed to cool in the fridge for 30 min. The agarose block was removed from each tube and cut into 1 mm<sup>3</sup> pieces. The samples were then dehydrated by microwave processing using the Pelco Biowave® Pro+ incorporating the Pelco Coldspot® Pro. In the vacuum chamber, samples were rinsed 3 times in buffer (150 watts for 40s), then treated in 1% osmium, pulsed (100 watts for 8 min) and rinsed 3 times in distilled water (150 watts for 40s). They were then taken out of the vaccum chamber and a graded series of dried acetone was applied to the samples (25%, 50%,75%, and 3 times in 100%, at 150 watts for 40 s for each step). This was followed by impregnation with a series of increasing concentrations of epoxy resin (Taab Medium resin) in acetone (25%, 50%,75%, 3 times in 100% at 300 watts for 3 min. for each step). Samples were embedded in fresh 100% resin and polymerised at 60°C for 24 h in a conventional oven. Once polymerised the resin block were cut in semi-thin survey sections (0.5 µm) and stained with 1% toluidine blue in 1% borax. Ultrathin sections (70 nm approx.) were then cut using a diamond knife on a Leica EM UC7 ultramicrotome. The sections were stretched with chloroform to eliminate compression and mounted on Pioloform-filmed copper grids. Grids were stained with uranyl acetate (2%) and Lead citrate and viewed on a Hitachi HT7800 transmission electron microscope using an Emsis Xarosa camera.</p></sec><sec id="S20"><title>Samples preparation for LTA polymer detection</title><p id="P55"><italic>B. subtilis</italic> strains were grown overnight at 30°C with shaking in NB supplemented with 5 mM MgS0<sub>4</sub> (or 10 mM for <italic>mbl</italic> mutants). The cells were then diluted (1:60-1:80 depending on the strain) to an approximate OD<sub>600nm</sub> of 0.02 in prewarmed NB and NB supplemented with 0.2% glucose. Strains were then incubated at 37°C shaking and grown for about 4.5 h (late exponential phase). At the sampling time the OD<sub>600nm</sub>of the cultures were measured before harvesting 15-25 ml of culture at 3273 <italic>g</italic> for 10 min, using a swing out centrifuge at room temperature. Pellets were washed with 200 μl of solution A (with 10 mL of Tris-HCl at 100 mM pH 7.4 and one cOmplete Mini EDTA-free tablet of protease inhibitor cocktail from Roche) and pelleted with benchtop centrifuge. Cells pellets were then frozen in liquid nitrogen and stored at -20°C until processing. Samples were resuspended in a volume of solution B (an equal volume of solution A and LDS sample buffer, Life Technologies) ranging from 70 to 200 μl in proportion to their OD<sub>600nm</sub>. Samples were boiled 30 min at 100°C, cooled down on ice for 3 min and incubated each with 100 U of benzonase (E1014, Sigma) for 30 min at 37°C. Samples were pelleted at 4°C, supernatants containing the extracted LTA were collected. Supernatants were frozen in liquid nitrogen and kept at -25°C. For the LTA Western blots, the quantity of sample loaded was normalized using the Bio-Rad Protein assays such that the final OD<sub>595nm</sub> was approximately 0.35. Sample sets to be compared were grown, extracted, measured and normalized together for each experiment.</p><p id="P56"><italic>S. aureus</italic> strains were grown overnight at 37°C with shaking in LB. The cells were then diluted (about 300-fold) to an approximate OD<sub>600nm</sub> of about 0.02 and grown in LB at 37°C until reaching late exponential and an OD<sub>600nm</sub> of about 1. 10 ml of cultures were harvested, and samples were prepared as for <italic>B. subtilis</italic> with the following changes: 60 μl of solution B were used and about 18-20 μl of samples were loaded on SDS-PAGE with samples normalised to their OD<sub>600nm</sub>.</p></sec><sec id="S21"><title>Total protein samples preparation</title><p id="P57">For LytE or LtaS Western blots, cells were grown, harvested and processed in the same way as the LTA-samples, with the exception that to detect the His tagged proteins (LytE, LtaS or YfnI) the strains were grown in presence of erythromycin. An 8 ml culture sample was resuspended in 180-200 μl of a solution A and sonicated until a clear lysate was obtained. Samples were centrifuged at 16,000 <italic>g</italic> for 10 min at 4°C and a volume of sample supernatant loaded on the SDS-gel, normalized based on the OD<sub>600nm</sub> of the cells culture collected.</p></sec><sec id="S22"><title>SDS-PAGE, LTA and proteins Western blots, detection blots</title><p id="P58">For SDS-PAGE, samples were diluted in solution B with the addition of reducing agent (1.5 μl per sample) in final volume of 20 μl, heated at 70°C for 10 min, loaded on the gel (NuPAGE 4-12% Bis-Tris gradient Midi Gel, Life Technologies) and separated by electrophoresis. For the LTA-PBP2B experiment, MES buffer, Novex Sharp prestained protein Ladder (Life Technologies) and 0.2 µm Amersham Hybond sequencing PVDF membrane (GE Healthcare) were used. Whereas for LytE (37 kDa) or LtaS (74 kDa) Western blots, MOPS buffer, Abcam prestained mid-range protein ladder (Ab116027) and 0.45 µM Amersham Hybond PVDF membrane (GE Healthcare) were used. The SDS-PAGE gels were transferred to membranes using the Trans-Blot Turbo transfer system (Bio-Rad) using an in-house transfer buffer (tris 600 mM, glycine 600 mM, tricine 280 mM, EDTA 2.5 mM and SDS 0.05%). After transfer, the membranes were washed 3x 5 min in PBS using a rocking shaker, afterwards the membranes were cut where required to allow different detection methods.</p><p id="P59">For the LTA Western blot, membrane was cut at the 60 kDa ladder position. The bottom part of the membrane was used for the LTA-blot whereas the top part was used to detect the membrane protein PBP2B (79 kDa) as a loading/extraction control. All LTA Western blot steps were performed at room temperature in a rolling shaker and using 50 mL falcon tubes. The LTA-membranes were incubated 1h15 in PBS buffer with 3% BSA (A7030, Sigma), then 1h30 in fresh PBS-3% BSA with a dilution 1:1000 of Gram-positive LTA monoclonal antibody (MA1-7402, Thermofischer). The membrane was then washed briefly 2 times, followed by 4x 8 min in PBS and then incubated in PBS-5% dried semi-skimmed milk with 1:10,000 anti-mouse HRP-linked secondary antibody (A9044, Sigma) for 1 h. This was then followed by 2 brief and 6x 8 min washes steps prior to detection.</p><p id="P60">For proteins Western blots to detect LytE-His<sub>12</sub> or LtaS and PBP2B, all the following steps were performed at room temperature using a rocking shaker. The membranes were washed after transfer in PBS-Tween20 at 0.1% (here after noted PBS-T) and blocked in PBS-T with 5% milk for 1h15 (i.e PBS-T-milk) at room temperature. Thereafter the LytE-His<sub>12</sub>/PBP2B membrane blot was cut at about 53 kDa ladder position. Membranes were placed in fresh buffer PBS-T-milk for 1h (or 1h30 when performing the LTAs western blot in parallel) with the polyclonal rabbit anti-PBP2B antibody (at 1:5000, lab. stock or available at Merck ABS2199), the mouse monoclonal Penta-His antibody (Qiagen n°34660 stock at 200 µg/ml, used at dilution 1:2000) or polyclonal rabbit anti-LtaS antibody (at 1:1000, lab. stock). Two brief washing steps were performed in PBS-T followed by 3 washes of 10 min. Membranes were incubated in PBS-T-milk for 1 h using 1:10000 dilutions of anti-rabbit or anti-mouse HRP-linked secondary antibodies (A0545 or A9044 Sigma antibodies, respectively) as required. Membranes were then washed as described at the previous step.</p><p id="P61">Pierce ECL Plus Western Blotting Substrate (32132, Thermo Scientific) was used for detection as recommended by manufacturer. Chemiluminescence was detected using ImageQuant LAS 4000 mini digital imaging system (GE Healthcare) and membranes were exposed with 1 min increment for 20 min. Membranes were also imaged by Epi-illumination to detect the pre-stained proteins ladder on the membrane. In our conditions, quantities of LTAs samples loaded were scaled down to avoid burn out of signals observed in some of the tested strains. Occasionally for the LTAs blot, strains (in NB-only) can display a very weak signal above the 30 kDa ladder position. This phenomenon was observed by others performing <italic>Bacillus</italic> LTA Western blots and was assumed not to be related to LTA but possibly a cross-reactivity of the antibody to WTAs that also contains glycerolphosphate (<xref ref-type="bibr" rid="R18">18</xref>).</p><p id="P62">Images were edited in ImageJ (Fiji), the same contrast enhancement was applied for the membranes of the same set experiment. Three independent sets of experimental samples were generated by Western blots. Contrast was sometimes added to the images, in particular to observe LytE signal in low-expressing strains.</p></sec><sec id="S23"><title>LytE purification and raising antiserum</title><p id="P63">Plasmid pAM-21 was transferred into <italic>E. coli</italic> BL21 (DE3) strain. Newly obtained strain grew at 37°C in LB kanamycin, when cell reached an approximative OD<sub>600nm</sub>of 0.5 <italic>lytE</italic> expression was induced with 1 mM IPTG for 3 h. 50 ml culture was collected by centrifugation at 9,000 <italic>g</italic> for 5 min and resuspended in 15 ml of a solution of PBS at 4 µg/ml of lysosyme. After incubation for 20 min at room temperature (RT), cells were sonicated, and once clear lysate was obtained cells were harvested at 3,000 <italic>g</italic> for 4 min. The cell pellet was resuspended in PBS buffer at 8 M Urea and incubated for 30 min at RT on a rolling shaker. The cells were then centrifuged at 9,000 <italic>g</italic> for 10 min and supernatant was collected and mixed gently with 200 µl of Ni Sepharose High Performance (GE Healthcare) and incubated for 1 h in same condition as above. Then the sample was washed 3 to 4 times in buffer A (50 mM Tris (pH 8) and 300 mM NaCl), and the last wash was done in buffer B (50 mM Tris, 300 mM NaCl, 5 mM Imidazole). Sample was eluted five times in buffer C (PBS at 8 M Urea and 100 mM imidazole) and elution fractions were analysed by SDS-PAGE. Ice-cold acetone was added at a 4:1 volume ratio to the desired eluted sample and incubated overnight at -20°C. Sample was centrifuged at 4 °C for 10 min at 15,000 <italic>g</italic> and the pellet was left to dry at RT. The pellet was suspended in 200 µl of PBS and 100 µg aliquot was sent to raise antiserum (Eurogentec). The LytE antiserum was used in Western blot at 1:5000 dilution and with the anti-rabbit secondary antibody (1:10000).</p></sec><sec id="S24"><title>Growth assays in presence of Daptomycin</title><p id="P64">For the <italic>S. aureus</italic> samples for LTA Western blot, cultures were done as previously described but after 3h growing in LB, CaCl<sub>2</sub> (1.25 mM final) was added to the cultures which were then divided and grown an extra hour with or without daptomycin (Dap stock at 1 mg/ml, Abcam ab141204).</p><p id="P65">For the NA-CaCl<sub>2</sub> DAP assays, strains were exponentially growing in NB for about 3h at 37°C (exponential phase) and then normalized to an OD<sub>600nm</sub> of 0.5. Cells (300 µl) were spread on calibrated NA plate supplemented with CaCl<sub>2</sub> (1.25 mM final). A daptomycin 0.016-256 mg/l antimicrobial susceptibility testing strip (Liofilchem) was applied to the medium surface. Plates were incubated at 37°C overnight and scanned after 24h. Images were edited in Fiji (ImageJ). Interpretation on growth inhibition follows manufacturer’s guidance.</p><p id="P66">To monitor strain growth in a plate reader, we used pre-cultures which has grown in NB (or in LB for <italic>S. aureus</italic>) at 37°C for about 3h. For each assays, a daptomycin stock at 17.4 mg/ml was used to prepare a fresh DAP stock at 0.1 mg/ml and this was used to make dilutions of the antibiotic as required in 96-wells plates in 100 µl of medium supplemented with CaCl<sub>2</sub> (1.25mM final). Plates were then loaded with 100 µl of cells (diluted in medium-CaCl<sub>2</sub> and normalized at the desired OD<sub>600nm</sub>). Plates were shaken at 37°C in a Tecan Sunrise plate reader and the OD<sub>600nm</sub> was measured every 6 min. Conditions were tested in duplicate or triplicates whenever possible. Data were collected using Magellan software (version 7.2). Microsoft Excel was used for analysis and generating graphs.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>supplemental figures</label><media xlink:href="EMS154565-supplement-supplemental_figures.pdf" mimetype="application" mime-subtype="pdf" id="d63aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S25"><title>Acknowledgments</title><p>The authors thank P. Aldridge for critical reading of the manuscript. The authors thank colleagues for strains, genomic DNAs or daptomycin stock: S. Moore, P. Dominguez-Cuevas, P. Gamba, A. Koh, K. Seistrup, L. Bowman, J. Buttress, H. Strahl and J. D. Helmann, B. M. Wendel and A. Peschel for strains related to daptomycin resistance. Technical support was provided by I. Selmes, F. Davison and T. Fletcher and TEM sample processing by Tracey Davey in the Electron Microscopy Research Services Newcastle University (funded through the BBSRC; BB/R013942/1). The authors thank J. Errington for the anti-LtaS antibody, H. Strahl and W. Vollmer for helpful discussion, C. Winterhalter and S. Fenyk for advice on Western blots and P. Tiago for sharing subtiwiki data. This work was funded by grants from the BBSRC (BB/G015902/1), EPSRC (EP/N031962/1) (RAD and AG) and SACB (studentship for AA).</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P67"><bold>Author contributions</bold></p><p id="P68">Conceptualization: AG; Funding acquisition, RAD; Methodology: AG; Investigation: AG and AA; Methodology: AG; Project administration: RAD; Supervision: RAD; Validation: AG; Visualization: AG; Writing—original draft: AG; Writing—review &amp; editing: AG and RAD.</p></fn><fn id="FN2" fn-type="conflict"><p id="P69"><bold>Conflict of interest</bold></p><p id="P70">The authors declare that they have no conflict of interest.</p></fn><fn id="FN3"><p id="P71"><bold>Supporting information</bold></p><p id="P72">Figures, Tables and Supplemental Figures are available for this manuscript. This study includes no data deposited in external repositories.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>BR</given-names></name><name><surname>Neely</surname><given-names>MN</given-names></name></person-group><article-title>Coordinate regulation of Gram-positive cell surface components</article-title><source>Curr Opin Microbiol</source><year>2012</year><volume>15</volume><fpage>204</fpage><lpage>10</lpage></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Percy</surname><given-names>MG</given-names></name><name><surname>Grundling</surname><given-names>A</given-names></name></person-group><article-title>Lipoteichoic Acid Synthesis and Function in Gram-Positive Bacteria</article-title><source>Annu Rev Microbiol</source><year>2014</year><pub-id pub-id-type="doi">10.1146/annurev-micro-091213-112949</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneewind</surname><given-names>O</given-names></name><name><surname>Missiakas</surname><given-names>D</given-names></name></person-group><article-title>Lipoteichoic acid synthesis and function in gram-positive bacteria</article-title><source>Biogenesis of Fatty Acids, Lipids and Membranes</source><year>2016</year><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajagopal</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>Envelope Structures of Gram-Positive Bacteria</article-title><source>Curr Top Microbiol Immunol</source><year>2017</year><volume>404</volume><fpage>1</fpage><lpage>44</lpage></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuhaus</surname><given-names>FC</given-names></name><name><surname>Baddiley</surname><given-names>J</given-names></name></person-group><article-title>A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria</article-title><source>Microbiol Mol Biol Rev</source><year>2003</year><volume>67</volume><fpage>686</fpage><lpage>723</lpage></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>HP</given-names></name></person-group><article-title>How Teichoic Acids Could Support a Periplasm in Gram-Positive Bacteria, and Let Cell Division Cheat Turgor Pressure</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><elocation-id>664704</elocation-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazos</surname><given-names>M</given-names></name><name><surname>Vollmer</surname><given-names>W</given-names></name></person-group><article-title>Regulation and function of class A Penicillin-binding proteins</article-title><source>Curr Opin Microbiol</source><year>2021</year><volume>60</volume><fpage>80</fpage><lpage>87</lpage></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straume</surname><given-names>D</given-names></name><name><surname>Piechowiak</surname><given-names>KW</given-names></name><name><surname>Kjos</surname><given-names>M</given-names></name><name><surname>Havarstein</surname><given-names>LS</given-names></name></person-group><article-title>Class A PBPs: It is time to rethink traditional paradigms</article-title><source>Mol Microbiol</source><year>2021</year><pub-id pub-id-type="doi">10.1111/mmi.14714</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname><given-names>DC</given-names></name><name><surname>Popham</surname><given-names>DL</given-names></name></person-group><article-title>Peptidoglycan synthesis in the absence of class A penicillin-binding proteins in <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>2003</year><volume>185</volume><fpage>1423</fpage><lpage>31</lpage></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Daniel</surname><given-names>RA</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>Regulation of cell wall morphogenesis in <italic>Bacillus subtilis</italic> by recruitment of PBP1 to the MreB helix</article-title><source>Mol Microbiol</source><year>2009</year><volume>71</volume><fpage>1131</fpage><lpage>44</lpage></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meeske</surname><given-names>AJ</given-names></name><name><surname>Riley</surname><given-names>EP</given-names></name><name><surname>Robins</surname><given-names>WP</given-names></name><name><surname>Uehara</surname><given-names>T</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name><name><surname>Kahne</surname><given-names>D</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name><name><surname>Kruse</surname><given-names>AC</given-names></name><name><surname>Bernhardt</surname><given-names>TG</given-names></name><name><surname>Rudner</surname><given-names>DZ</given-names></name></person-group><article-title>SEDS proteins are a widespread family of bacterial cell wall polymerases</article-title><source>Nature</source><year>2016</year><volume>537</volume><fpage>634</fpage><lpage>638</lpage></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emami</surname><given-names>K</given-names></name><name><surname>Guyet</surname><given-names>A</given-names></name><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Devi</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>LJ</given-names></name><name><surname>Allenby</surname><given-names>N</given-names></name><name><surname>Daniel</surname><given-names>RA</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>RodA as the missing glycosyltransferase in <italic>Bacillus subtilis</italic> and antibiotic discovery for the peptidoglycan polymerase pathway</article-title><source>Nat Microbiol</source><year>2017</year><volume>2</volume><elocation-id>16253</elocation-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname><given-names>T</given-names></name><name><surname>Page</surname><given-names>JE</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>Uncovering the activities, biological roles, and regulation of bacterial cell wall hydrolases and tailoring enzymes</article-title><source>J Biol Chem</source><year>2020</year><volume>295</volume><fpage>3347</fpage><lpage>3361</lpage></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>S</given-names></name><name><surname>Garner</surname><given-names>E</given-names></name></person-group><article-title>An Exhaustive Multiple Knockout Approach to Understanding Cell Wall Hydrolase Function in <italic>Bacillus subtilis</italic></article-title><source>bioRxiv</source><year>2021</year><pub-id pub-id-type="doi">10.1101/2021.02.18.431929:2021.02.18.431929</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunet</surname><given-names>YR</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Rudner</surname><given-names>DZ</given-names></name></person-group><article-title>SweC and SweD are essential co-factors of the FtsEX-CwlO cell wall hydrolase complex in <italic>Bacillus subtilis</italic></article-title><source>PLoS Genet</source><year>2019</year><volume>15</volume><elocation-id>e1008296</elocation-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirner</surname><given-names>K</given-names></name><name><surname>Marles-Wright</surname><given-names>J</given-names></name><name><surname>Lewis</surname><given-names>RJ</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>Distinct and essential morphogenic functions for wall- and lipo-teichoic acids in <italic>Bacillus subtilis</italic></article-title><source>EMBO J</source><year>2009</year><volume>28</volume><fpage>830</fpage><lpage>42</lpage></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soldo</surname><given-names>B</given-names></name><name><surname>Lazarevic</surname><given-names>V</given-names></name><name><surname>Karamata</surname><given-names>D</given-names></name></person-group><article-title><italic>tagO</italic> is involved in the synthesis of all anionic cell-wall polymers in <italic>Bacillus subtilis</italic> 168</article-title><source>Microbiology (Reading)</source><year>2002</year><volume>148</volume><fpage>2079</fpage><lpage>2087</lpage></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wormann</surname><given-names>ME</given-names></name><name><surname>Corrigan</surname><given-names>RM</given-names></name><name><surname>Simpson</surname><given-names>PJ</given-names></name><name><surname>Matthews</surname><given-names>SJ</given-names></name><name><surname>Grundling</surname><given-names>A</given-names></name></person-group><article-title>Enzymatic activities and functional interdependencies of <italic>Bacillus subtilis</italic> lipoteichoic acid synthesis enzymes</article-title><source>Mol Microbiol</source><year>2011</year><volume>79</volume><fpage>566</fpage><lpage>83</lpage></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneewind</surname><given-names>O</given-names></name><name><surname>Missiakas</surname><given-names>D</given-names></name></person-group><article-title>Lipoteichoic acids, phosphate-containing polymers in the envelope of Gram-positive bacteria</article-title><source>J Bacteriol</source><year>2014</year><volume>196</volume><fpage>1133</fpage><lpage>42</lpage></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname><given-names>AW</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>Contributions of the σ<sup>W</sup>, σ<sup>M</sup> and σ<sup>X</sup> regulons to the lantibiotic resistome of <italic>Bacillus subtilis</italic></article-title><source>Mol Microbiol</source><year>2013</year><volume>90</volume><fpage>502</fpage><lpage>18</lpage></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peschel</surname><given-names>A</given-names></name><name><surname>Jack</surname><given-names>RW</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>LV</given-names></name><name><surname>Staubitz</surname><given-names>P</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Kalbacher</surname><given-names>H</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>WF</given-names></name><name><surname>Jung</surname><given-names>G</given-names></name><name><surname>Tarkowski</surname><given-names>A</given-names></name><name><surname>van Kessel</surname><given-names>KP</given-names></name><etal/></person-group><article-title><italic>Staphylococcus aureus</italic> resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine</article-title><source>J Exp Med</source><year>2001</year><volume>193</volume><fpage>1067</fpage><lpage>76</lpage></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slavetinsky</surname><given-names>C</given-names></name><name><surname>Kuhn</surname><given-names>S</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><article-title>Bacterial aminoacyl phospholipids - Biosynthesis and role in basic cellular processes and pathogenicity</article-title><source>Biochim Biophys Acta Mol Cell Biol Lipids</source><year>2017</year><volume>1862</volume><fpage>1310</fpage><lpage>1318</lpage></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staubitz</surname><given-names>P</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><article-title>MprF-mediated lysinylation of phospholipids in <italic>Bacillus subtilis</italic> - protection against bacteriocins in terrestrial habitats?</article-title><source>Microbiology</source><year>2002</year><volume>148</volume><fpage>3331</fpage><lpage>2</lpage></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>CM</given-names></name><name><surname>Grossman</surname><given-names>AD</given-names></name></person-group><article-title>The Composition of the Cell Envelope Affects Conjugation in <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>2016</year><volume>198</volume><fpage>1241</fpage><lpage>9</lpage></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atila</surname><given-names>M</given-names></name><name><surname>Katselis</surname><given-names>G</given-names></name><name><surname>Chumala</surname><given-names>P</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Characterization of N-Succinylation of L-Lysylphosphatidylglycerol in <italic>Bacillus subtilis</italic> Using Tandem Mass Spectrometry</article-title><source>J Am Soc Mass Spectrom</source><year>2016</year><volume>27</volume><fpage>1606</fpage><lpage>13</lpage></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>CM</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><article-title>MprF-mediated daptomycin resistance</article-title><source>Int J Med Microbiol</source><year>2019</year><volume>309</volume><fpage>359</fpage><lpage>363</lpage></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>J</given-names></name><name><surname>Visnovsky</surname><given-names>SB</given-names></name><name><surname>Cruz</surname><given-names>CD</given-names></name><name><surname>Fletcher</surname><given-names>GC</given-names></name><name><surname>van Vliet</surname><given-names>AHM</given-names></name><name><surname>Hedderley</surname><given-names>D</given-names></name><name><surname>Butler</surname><given-names>R</given-names></name><name><surname>Flint</surname><given-names>S</given-names></name><name><surname>Palmer</surname><given-names>J</given-names></name><name><surname>Pitman</surname><given-names>AR</given-names></name></person-group><article-title>Inactivation of the gene encoding the cationic antimicrobial peptide resistance factor MprF increases biofilm formation but reduces invasiveness of <italic>Listeria monocytogenes</italic></article-title><source>J Appl Microbiol</source><year>2021</year><volume>130</volume><fpage>464</fpage><lpage>477</lpage></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzberg</surname><given-names>LI</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>Phenotypic and transcriptomic characterization of <italic>Bacillus subtilis</italic> mutants with grossly altered membrane composition</article-title><source>J Bacteriol</source><year>2008</year><volume>190</volume><fpage>7797</fpage><lpage>807</lpage></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hachmann</surname><given-names>AB</given-names></name><name><surname>Angert</surname><given-names>ER</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>Genetic analysis of factors affecting susceptibility of <italic>Bacillus subtilis</italic> to daptomycin</article-title><source>Antimicrob Agents Chemother</source><year>2009</year><volume>53</volume><fpage>1598</fpage><lpage>609</lpage></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorasch</surname><given-names>P</given-names></name><name><surname>Wolter</surname><given-names>FP</given-names></name><name><surname>Zahringer</surname><given-names>U</given-names></name><name><surname>Heinz</surname><given-names>E</given-names></name></person-group><article-title>A UDP glucosyltransferase from <italic>Bacillus subtilis</italic> successively transfers up to four glucose residues to 1,2-diacylglycerol: expression of <italic>ypfP Escherichia coli</italic> and structural analysis of its reaction products</article-title><source>Mol Microbiol</source><year>1998</year><volume>29</volume><fpage>419</fpage><lpage>30</lpage></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarevic</surname><given-names>V</given-names></name><name><surname>Soldo</surname><given-names>B</given-names></name><name><surname>Medico</surname><given-names>N</given-names></name><name><surname>Pooley</surname><given-names>H</given-names></name><name><surname>Bron</surname><given-names>S</given-names></name><name><surname>Karamata</surname><given-names>D</given-names></name></person-group><article-title><italic>Bacillus subtilis</italic> α-phosphoglucomutase is required for normal cell morphology and biofilm formation</article-title><source>Appl Environ Microbiol</source><year>2005</year><volume>71</volume><fpage>39</fpage><lpage>45</lpage></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundling</surname><given-names>A</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name></person-group><article-title>Genes required for glycolipid synthesis and lipoteichoic acid anchoring in <italic>Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2007</year><volume>189</volume><fpage>2521</fpage><lpage>30</lpage></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesser</surname><given-names>AR</given-names></name><name><surname>Schaefer</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>Lipoteichoic acid polymer length is determined by competition between free starter units</article-title><source>Proc Natl Acad Sci U S A</source><year>2020</year><volume>117</volume><fpage>29669</fpage><lpage>29676</lpage></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oku</surname><given-names>Y</given-names></name><name><surname>Kurokawa</surname><given-names>K</given-names></name><name><surname>Matsuo</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>BL</given-names></name><name><surname>Sekimizu</surname><given-names>K</given-names></name></person-group><article-title>Pleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of <italic>Staphylococcus aureus</italic> cells</article-title><source>J Bacteriol</source><year>2009</year><volume>191</volume><fpage>141</fpage><lpage>51</lpage></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coe</surname><given-names>KA</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Stone</surname><given-names>MC</given-names></name><name><surname>Komazin-Meredith</surname><given-names>G</given-names></name><name><surname>Meredith</surname><given-names>TC</given-names></name><name><surname>Grad</surname><given-names>YH</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>Multi-strain Tn-Seq reveals common daptomycin resistance determinants in <italic>Staphylococcus aureus</italic></article-title><source>PLoS Pathog</source><year>2019</year><volume>15</volume><elocation-id>e1007862</elocation-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundling</surname><given-names>A</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name></person-group><article-title>Synthesis of glycerol phosphate lipoteichoic acid in <italic>Staphylococcus aureus</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>8478</fpage><lpage>83</lpage></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Seki</surname><given-names>T</given-names></name><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Sadaie</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group><article-title>Induction of extracytoplasmic function sigma factors in <italic>Bacillus subtilis</italic> cells with defects in lipoteichoic acid synthesis</article-title><source>Microbiology</source><year>2013</year><volume>159</volume><fpage>23</fpage><lpage>35</lpage></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>T</given-names></name><name><surname>Popham</surname><given-names>DL</given-names></name><name><surname>Setlow</surname><given-names>P</given-names></name></person-group><article-title><italic>Bacillus subtilis</italic> cells lacking penicillin-binding protein 1 require increased levels of divalent cations for growth</article-title><source>J Bacteriol</source><year>1998</year><volume>180</volume><fpage>4555</fpage><lpage>63</lpage></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claessen</surname><given-names>D</given-names></name><name><surname>Emmins</surname><given-names>R</given-names></name><name><surname>Hamoen</surname><given-names>LW</given-names></name><name><surname>Daniel</surname><given-names>RA</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name><name><surname>Edwards</surname><given-names>DH</given-names></name></person-group><article-title>Control of the cell elongation-division cycle by shuttling of PBP1 protein in <italic>Bacillus subtilis</italic></article-title><source>Mol Microbiol</source><year>2008</year><volume>68</volume><fpage>1029</fpage><lpage>46</lpage></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perego</surname><given-names>M</given-names></name><name><surname>Glaser</surname><given-names>P</given-names></name><name><surname>Minutello</surname><given-names>A</given-names></name><name><surname>Strauch</surname><given-names>MA</given-names></name><name><surname>Leopold</surname><given-names>K</given-names></name><name><surname>Fischer</surname><given-names>W</given-names></name></person-group><article-title>Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in <italic>Bacillus subtilis</italic> Identification of genes and regulation</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>15598</fpage><lpage>606</lpage></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>BM</given-names></name><name><surname>Santa Maria</surname><given-names>JP</given-names><suffix>Jr</suffix></name><name><surname>Matano</surname><given-names>LM</given-names></name><name><surname>Vickery</surname><given-names>CR</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>A partial reconstitution implicates DltD in catalyzing lipoteichoic acid d-alanylation</article-title><source>J Biol Chem</source><year>2018</year><volume>293</volume><fpage>17985</fpage><lpage>17996</lpage></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>Partial functional redundancy of MreB isoforms, MreB, Mbl and MreBH, in cell morphogenesis of <italic>Bacillus subtilis</italic></article-title><source>Mol Microbiol</source><year>2009</year><volume>73</volume><fpage>719</fpage><lpage>31</lpage></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Cuevas</surname><given-names>P</given-names></name><name><surname>Porcelli</surname><given-names>I</given-names></name><name><surname>Daniel</surname><given-names>RA</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>Differentiated roles for MreB-actin isologues and autolytic enzymes in <italic>Bacillus subtilis</italic> morphogenesis</article-title><source>Mol Microbiol</source><year>2013</year><volume>89</volume><fpage>1084</fpage><lpage>98</lpage></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Ooiwa</surname><given-names>S</given-names></name><name><surname>Sekiguchi</surname><given-names>J</given-names></name></person-group><article-title>Synthetic lethality of the <italic>lytE cwlO</italic> genotype in <italic>Bacillus subtilis</italic> is caused by lack of D,L-endopeptidase activity at the lateral cell wall</article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><fpage>796</fpage><lpage>803</lpage></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzberg</surname><given-names>LI</given-names></name><name><surname>Powell</surname><given-names>L</given-names></name><name><surname>Hokamp</surname><given-names>K</given-names></name><name><surname>Botella</surname><given-names>E</given-names></name><name><surname>Noone</surname><given-names>D</given-names></name><name><surname>Devine</surname><given-names>KM</given-names></name></person-group><article-title>The WalRK (YycFG) and σ<sup>1</sup> RsgI regulators cooperate to control CwlO and LytE expression in exponentially growing and stressed <italic>Bacillus subtilis</italic> cells</article-title><source>Mol Microbiol</source><year>2013</year><volume>87</volume><fpage>180</fpage><lpage>95</lpage></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobihal</surname><given-names>GS</given-names></name><name><surname>Brunet</surname><given-names>YR</given-names></name><name><surname>Flores-Kim</surname><given-names>J</given-names></name><name><surname>Rudner</surname><given-names>DZ</given-names></name></person-group><article-title>Homeostatic control of cell wall hydrolysis by the WalRK two-component signaling pathway in <italic>Bacillus subtilis</italic></article-title><source>Elife</source><year>2019</year><volume>8</volume></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasahara</surname><given-names>J</given-names></name><name><surname>Kiriyama</surname><given-names>Y</given-names></name><name><surname>Miyashita</surname><given-names>M</given-names></name><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Yazawa</surname><given-names>K</given-names></name><name><surname>Yoshikawa</surname><given-names>R</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name></person-group><article-title>Teichoic Acid Polymers Affect Expression and Localization of dl-Endopeptidase LytE Required for Lateral Cell Wall Hydrolysis in <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>2016</year><volume>198</volume><fpage>1585</fpage><lpage>1594</lpage></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamou</surname><given-names>G</given-names></name><name><surname>Fiyaksel</surname><given-names>O</given-names></name><name><surname>Sinai</surname><given-names>L</given-names></name><name><surname>Ben-Yehuda</surname><given-names>S</given-names></name></person-group><article-title>Deficiency in Lipoteichoic Acid Synthesis Causes a Failure in Executing the Colony Developmental Program in <italic>Bacillus subtilis</italic></article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><elocation-id>1991</elocation-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>A</given-names></name><name><surname>Wenzel</surname><given-names>M</given-names></name><name><surname>Strahl</surname><given-names>H</given-names></name><name><surname>Grein</surname><given-names>F</given-names></name><name><surname>Saaki</surname><given-names>TNV</given-names></name><name><surname>Kohl</surname><given-names>B</given-names></name><name><surname>Siersma</surname><given-names>T</given-names></name><name><surname>Bandow</surname><given-names>JE</given-names></name><name><surname>Sahl</surname><given-names>HG</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Hamoen</surname><given-names>LW</given-names></name></person-group><article-title>Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><fpage>E7077</fpage><lpage>E7086</lpage></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>DA</given-names></name><name><surname>Wenzel</surname><given-names>M</given-names></name></person-group><article-title>More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin</article-title><source>Antibiotics (Basel)</source><year>2020</year><volume>9</volume></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grein</surname><given-names>F</given-names></name><name><surname>Muller</surname><given-names>A</given-names></name><name><surname>Scherer</surname><given-names>KM</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ludwig</surname><given-names>KC</given-names></name><name><surname>Klockner</surname><given-names>A</given-names></name><name><surname>Strach</surname><given-names>M</given-names></name><name><surname>Sahl</surname><given-names>HG</given-names></name><name><surname>Kubitscheck</surname><given-names>U</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name></person-group><article-title>Ca<sup>2+</sup>-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>1455</elocation-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>L</given-names></name><name><surname>Alder</surname><given-names>JD</given-names></name><name><surname>Silverman</surname><given-names>JA</given-names></name></person-group><article-title>Genetic changes that correlate with reduced susceptibility to daptomycin in <italic>Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>2006</year><volume>50</volume><fpage>2137</fpage><lpage>45</lpage></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>CM</given-names></name><name><surname>Slavetinsky</surname><given-names>CJ</given-names></name><name><surname>Kuhn</surname><given-names>S</given-names></name><name><surname>Hauser</surname><given-names>JN</given-names></name><name><surname>Nega</surname><given-names>M</given-names></name><name><surname>Mishra</surname><given-names>NN</given-names></name><name><surname>Gekeler</surname><given-names>C</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><article-title>Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance</article-title><source>mBio</source><year>2018</year><volume>9</volume></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hachmann</surname><given-names>AB</given-names></name><name><surname>Sevim</surname><given-names>E</given-names></name><name><surname>Gaballa</surname><given-names>A</given-names></name><name><surname>Popham</surname><given-names>DL</given-names></name><name><surname>Antelmann</surname><given-names>H</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in <italic>Bacillus subtilis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><fpage>4326</fpage><lpage>37</lpage></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesser</surname><given-names>AR</given-names></name><name><surname>Matano</surname><given-names>LM</given-names></name><name><surname>Vickery</surname><given-names>CR</given-names></name><name><surname>Wood</surname><given-names>BM</given-names></name><name><surname>Santiago</surname><given-names>AG</given-names></name><name><surname>Morris</surname><given-names>HG</given-names></name><name><surname>Do</surname><given-names>T</given-names></name><name><surname>Losick</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>The length of lipoteichoic acid polymers controls <italic>Staphylococcus aureus</italic> cell size and envelope integrity</article-title><source>J Bacteriol</source><year>2020</year><pub-id pub-id-type="doi">10.1128/JB.00149-20</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Kim</surname><given-names>J</given-names></name><name><surname>Dobihal</surname><given-names>GS</given-names></name><name><surname>Fenton</surname><given-names>A</given-names></name><name><surname>Rudner</surname><given-names>DZ</given-names></name><name><surname>Bernhardt</surname><given-names>TG</given-names></name></person-group><article-title>A switch in surface polymer biogenesis triggers growth-phase-dependent and antibiotic-induced bacteriolysis</article-title><source>Elife</source><year>2019</year><volume>8</volume></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>A regulatory pathway that selectively up-regulates elongasome function in the absence of class A PBPs</article-title><source>Elife</source><year>2020</year><volume>9</volume></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolas</surname><given-names>P</given-names></name><name><surname>Mader</surname><given-names>U</given-names></name><name><surname>Dervyn</surname><given-names>E</given-names></name><name><surname>Rochat</surname><given-names>T</given-names></name><name><surname>Leduc</surname><given-names>A</given-names></name><name><surname>Pigeonneau</surname><given-names>N</given-names></name><name><surname>Bidnenko</surname><given-names>E</given-names></name><name><surname>Marchadier</surname><given-names>E</given-names></name><name><surname>Hoebeke</surname><given-names>M</given-names></name><name><surname>Aymerich</surname><given-names>S</given-names></name><name><surname>Becher</surname><given-names>D</given-names></name><etal/></person-group><article-title>Condition-dependent transcriptome reveals high-level regulatory architecture in <italic>Bacillus subtilis</italic></article-title><source>Science</source><year>2012</year><volume>335</volume><fpage>1103</fpage><lpage>6</lpage></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Stulke</surname><given-names>J</given-names></name></person-group><article-title>SubtiWiki in 2018: from genes and proteins to functional network annotation of the model organism <italic>Bacillus subtilis</italic></article-title><source>Nucleic Acids Res</source><year>2018</year><volume>46</volume><fpage>D743</fpage><lpage>D748</lpage></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendel</surname><given-names>BM</given-names></name><name><surname>Pi</surname><given-names>H</given-names></name><name><surname>Kruger</surname><given-names>L</given-names></name><name><surname>Herzberg</surname><given-names>C</given-names></name><name><surname>Stulke</surname><given-names>J</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>A Central Role for Magnesium Homeostasis during Adaptation to Osmotic Stress</article-title><source>mBio</source><year>2022</year><pub-id pub-id-type="doi">10.1128/mbio.00092-22:e0009222</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesson</surname><given-names>B</given-names></name><name><surname>Dajkovic</surname><given-names>A</given-names></name><name><surname>Keary</surname><given-names>R</given-names></name><name><surname>Marliere</surname><given-names>C</given-names></name><name><surname>Dupont-Gillain</surname><given-names>CC</given-names></name><name><surname>Carballido-Lopez</surname><given-names>R</given-names></name></person-group><article-title>Magnesium rescues the morphology of <italic>Bacillus subtilis mreB</italic> mutants through its inhibitory effect on peptidoglycan hydrolases</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><elocation-id>1137</elocation-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Jiao</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title>Phospholipid translocation captured in a bifunctional membrane protein MprF</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><elocation-id>2927</elocation-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>LR</given-names></name><name><surname>Manzer</surname><given-names>HS</given-names></name><name><surname>da</surname><given-names>CMJ</given-names></name><name><surname>Villarreal</surname><given-names>R</given-names></name><name><surname>Nagao</surname><given-names>PE</given-names></name><name><surname>Doran</surname><given-names>KS</given-names></name><name><surname>Palmer</surname><given-names>KL</given-names></name><name><surname>Guan</surname><given-names>Z</given-names></name></person-group><article-title>Identification of a novel cationic glycolipid in <italic>Streptococcus agalactiae</italic> that contributes to brain entry and meningitis</article-title><source>PLoS Biol</source><year>2022</year><volume>20</volume><elocation-id>e3001555</elocation-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thitiananpakorn</surname><given-names>K</given-names></name><name><surname>Aiba</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>XE</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Kiga</surname><given-names>K</given-names></name><name><surname>Sato’o</surname><given-names>Y</given-names></name><name><surname>Boonsiri</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>FY</given-names></name><name><surname>Sasahara</surname><given-names>T</given-names></name><name><surname>Taki</surname><given-names>Y</given-names></name><name><surname>Azam</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Association of <italic>mprF</italic> mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA)</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><elocation-id>16107</elocation-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertsche</surname><given-names>U</given-names></name><name><surname>Yang</surname><given-names>SJ</given-names></name><name><surname>Kuehner</surname><given-names>D</given-names></name><name><surname>Wanner</surname><given-names>S</given-names></name><name><surname>Mishra</surname><given-names>NN</given-names></name><name><surname>Roth</surname><given-names>T</given-names></name><name><surname>Nega</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Grau</surname><given-names>T</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) clinical isolates</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><elocation-id>e67398</elocation-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>NN</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Weidenmaier</surname><given-names>C</given-names></name><name><surname>Grau</surname><given-names>T</given-names></name><name><surname>Wanner</surname><given-names>S</given-names></name><name><surname>Stefani</surname><given-names>S</given-names></name><name><surname>Cafiso</surname><given-names>V</given-names></name><name><surname>Bertuccio</surname><given-names>T</given-names></name><name><surname>Yeaman</surname><given-names>MR</given-names></name><name><surname>Nast</surname><given-names>CC</given-names></name><name><surname>Yang</surname><given-names>SJ</given-names></name></person-group><article-title>Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant <italic>Staphylococcus aureus</italic> strains: relative roles of <italic>mprF</italic> and <italic>dlt</italic> operons</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><elocation-id>e107426</elocation-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>SJ</given-names></name><name><surname>Nast</surname><given-names>CC</given-names></name><name><surname>Mishra</surname><given-names>NN</given-names></name><name><surname>Yeaman</surname><given-names>MR</given-names></name><name><surname>Fey</surname><given-names>PD</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name></person-group><article-title>Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in <italic>Staphylococcus aureus</italic> evidence for multiple resistance mechanisms</article-title><source>Antimicrob Agents Chemother</source><year>2010</year><volume>54</volume><fpage>3079</fpage><lpage>85</lpage></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muscato</surname><given-names>JD</given-names></name><name><surname>Morris</surname><given-names>HG</given-names></name><name><surname>Mychack</surname><given-names>A</given-names></name><name><surname>Rajagopal</surname><given-names>M</given-names></name><name><surname>Baidin</surname><given-names>V</given-names></name><name><surname>Hesser</surname><given-names>AR</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Inecik</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>LJ</given-names></name><name><surname>Kraml</surname><given-names>CM</given-names></name><name><surname>Meredith</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Rapid Inhibitor Discovery by Exploiting Synthetic Lethality</article-title><source>J Am Chem Soc</source><year>2022</year><volume>144</volume><fpage>3696</fpage><lpage>3705</lpage></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chee Wezen</surname><given-names>X</given-names></name><name><surname>Chandran</surname><given-names>A</given-names></name><name><surname>Eapen</surname><given-names>RS</given-names></name><name><surname>Waters</surname><given-names>E</given-names></name><name><surname>Bricio-Moreno</surname><given-names>L</given-names></name><name><surname>Tosi</surname><given-names>T</given-names></name><name><surname>Dolan</surname><given-names>S</given-names></name><name><surname>Millership</surname><given-names>C</given-names></name><name><surname>Kadioglu</surname><given-names>A</given-names></name><name><surname>Grundling</surname><given-names>A</given-names></name><name><surname>Itzhaki</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Structure-Based Discovery of Lipoteichoic Acid Synthase Inhibitors</article-title><source>J Chem Inf Model</source><year>2022</year><volume>62</volume><fpage>2586</fpage><lpage>2599</lpage></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slavetinsky</surname><given-names>CJ</given-names></name><name><surname>Hauser</surname><given-names>JN</given-names></name><name><surname>Gekeler</surname><given-names>C</given-names></name><name><surname>Slavetinsky</surname><given-names>J</given-names></name><name><surname>Geyer</surname><given-names>A</given-names></name><name><surname>Kraus</surname><given-names>A</given-names></name><name><surname>Heilingbrunner</surname><given-names>D</given-names></name><name><surname>Wagner</surname><given-names>S</given-names></name><name><surname>Tesar</surname><given-names>M</given-names></name><name><surname>Krismer</surname><given-names>B</given-names></name><name><surname>Kuhn</surname><given-names>S</given-names></name><etal/></person-group><article-title>Sensitizing <italic>Staphylococcus aureus</italic> to antibacterial agents by decoding and blocking the lipid flippase MprF</article-title><source>Elife</source><year>2022</year><volume>11</volume></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anagnostopoulos</surname><given-names>C</given-names></name><name><surname>Spizizen</surname><given-names>J</given-names></name></person-group><article-title>Requirements for Transformation in <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>1961</year><volume>81</volume><fpage>741</fpage><lpage>6</lpage></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamoen</surname><given-names>LW</given-names></name><name><surname>Smits</surname><given-names>WK</given-names></name><name><surname>de Jong</surname><given-names>A</given-names></name><name><surname>Holsappel</surname><given-names>S</given-names></name><name><surname>Kuipers</surname><given-names>OP</given-names></name></person-group><article-title>Improving the predictive value of the competence transcription factor (ComK) binding site in <italic>Bacillus subtilis</italic> using a genomic approach</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>5517</fpage><lpage>28</lpage></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>S</given-names></name><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Hiramatsu</surname><given-names>K</given-names></name><name><surname>Kuwano</surname><given-names>M</given-names></name><name><surname>Ogasawara</surname><given-names>N</given-names></name></person-group><article-title>A new FtsZ-interacting protein, YlmF, complements the activity of FtsA during progression of cell division in <italic>Bacillus subtilis</italic></article-title><source>Mol Microbiol</source><year>2006</year><volume>60</volume><fpage>1364</fpage><lpage>80</lpage></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surdova</surname><given-names>K</given-names></name><name><surname>Gamba</surname><given-names>P</given-names></name><name><surname>Claessen</surname><given-names>D</given-names></name><name><surname>Siersma</surname><given-names>T</given-names></name><name><surname>Jonker</surname><given-names>MJ</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name><name><surname>Hamoen</surname><given-names>LW</given-names></name></person-group><article-title>The conserved DNA-binding protein WhiA is involved in cell division in <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>2013</year><volume>195</volume><fpage>5450</fpage><lpage>60</lpage></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veening</surname><given-names>JW</given-names></name><name><surname>Kuipers</surname><given-names>OP</given-names></name><name><surname>Brul</surname><given-names>S</given-names></name><name><surname>Hellingwerf</surname><given-names>KJ</given-names></name><name><surname>Kort</surname><given-names>R</given-names></name></person-group><article-title>Effects of phosphorelay perturbations on architecture, sporulation, and spore resistance in biofilms of <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><fpage>3099</fpage><lpage>109</lpage></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinmetz</surname><given-names>M</given-names></name><name><surname>Richter</surname><given-names>R</given-names></name></person-group><article-title>Plasmids designed to alter the antibiotic resistance expressed by insertion mutations in <italic>Bacillus subtilis</italic> through in vivo recombination</article-title><source>Gene</source><year>1994</year><volume>142</volume><fpage>79</fpage><lpage>83</lpage></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Breton</surname><given-names>Y</given-names></name><name><surname>Mohapatra</surname><given-names>NP</given-names></name><name><surname>Haldenwang</surname><given-names>WG</given-names></name></person-group><article-title><italic>In vivo</italic> random mutagenesis of <italic>Bacillus subtilis</italic> by use of TnYLB-1, a mariner-based transposon</article-title><source>Appl Environ Microbiol</source><year>2006</year><volume>72</volume><fpage>327</fpage><lpage>33</lpage></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Formstone</surname><given-names>A</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>A magnesium-dependent <italic>mreB</italic> null mutant: implications for the role of <italic>mreB</italic><italic>Bacillus subtilis</italic></article-title><source>Mol Microbiol</source><year>2005</year><volume>55</volume><fpage>1646</fpage><lpage>57</lpage></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirner</surname><given-names>K</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>The cell wall regulator σ<sup>I</sup> specifically suppresses the lethal phenotype of <italic>mbl</italic> mutants in <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>2009</year><volume>191</volume><fpage>1404</fpage><lpage>13</lpage></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname><given-names>DC</given-names></name><name><surname>Driks</surname><given-names>A</given-names></name><name><surname>Popham</surname><given-names>DL</given-names></name></person-group><article-title>Two class A high-molecular-weight penicillin-binding proteins of <italic>Bacillus subtilis</italic> play redundant roles in sporulation</article-title><source>J Bacteriol</source><year>2001</year><volume>183</volume><fpage>6046</fpage><lpage>53</lpage></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branda</surname><given-names>SS</given-names></name><name><surname>Gonzalez-Pastor</surname><given-names>JE</given-names></name><name><surname>Dervyn</surname><given-names>E</given-names></name><name><surname>Ehrlich</surname><given-names>SD</given-names></name><name><surname>Losick</surname><given-names>R</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><article-title>Genes involved in formation of structured multicellular communities by <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>2004</year><volume>186</volume><fpage>3970</fpage><lpage>9</lpage></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>BM</given-names></name><name><surname>Kritikos</surname><given-names>G</given-names></name><name><surname>Farelli</surname><given-names>JD</given-names></name><name><surname>Todor</surname><given-names>H</given-names></name><name><surname>Tong</surname><given-names>K</given-names></name><name><surname>Kimsey</surname><given-names>H</given-names></name><name><surname>Wapinski</surname><given-names>I</given-names></name><name><surname>Galardini</surname><given-names>M</given-names></name><name><surname>Cabal</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>JM</given-names></name><name><surname>Hachmann</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Construction and Analysis of Two Genome-Scale Deletion Libraries for <italic>Bacillus subtilis</italic></article-title><source>Cell Syst</source><year>2017</year><volume>4</volume><fpage>291</fpage><lpage>305</lpage><elocation-id>e7</elocation-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Kamiya</surname><given-names>Y</given-names></name><name><surname>Miyazawa</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group><article-title>The <italic>Bacillus subtilis</italic> essential gene <italic>dgkB</italic> is dispensable in mutants with defective lipoteichoic acid synthesis</article-title><source>Genes Genet Syst</source><year>2011</year><volume>86</volume><fpage>365</fpage><lpage>76</lpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Representations of the cell envelope of Gram-positive rod-shaped bacterium <italic>Bacillus subtilis</italic> and the biosynthetic links between lipoteichoic acids and phospholipids.</title><p><bold>(A)</bold> Depiction of some of the cell envelope components and their function in <italic>B. subtilis</italic>. This figure indicates the complexity of the cell envelope synthesis due to the presence of enzymes that seemingly assume the same function. This redundancy of function has been identified in the reaction steps leading to the synthesis of the peptidoglycan (glycosyltransferases: 4 class A PBPs, PBP1/<italic>ponA</italic> major and the essential RodA), the lipoteichoic acids (3 LTA-synthases, where LtaS is the major enzyme) and the actin-like filaments that coordinate the cell shape (3 Mrehomologs: MreB/MreBH and Mbl where the latter is essential in <italic>B. subtilis</italic> 168CA). The major autolysins CwlO and LytE (the absence of both is lethal to <italic>B. subtilis</italic>) cleave the peptidoglycan pentapeptides. Presence of aminoacyl-phosphatidylglycerol (aaPGols) produced by MprF and the D-alanylation of teichoic acids by Dlt proteins are thought to create an electrostatic environment that protects the bacteria from CAMPs (cationic antimicrobial peptides).</p><p id="P73"><bold>(B)</bold> A schematic representation of the biosynthetic links between lipoteichoic acid, phospholipids and glucolipids in <italic>B. subtilis</italic>, adapted from previous studies (<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R83">83</xref>). Lipoteichoic acid (LTA) consist of glycerolphosphate units anchored to the membrane by a glycolipid. In absence of cytoplasmic UgtP, LTA polymer is linked to the membrane by a diacylglycerol (DAG), instead of a diglucosyldiacylglycerol (Glc<sub>2</sub>DAG). When grown in LB at 37°C, the majority of <italic>B. subtilis</italic> phospholipids are phosphatidylglycerol (PGol) (37.5% ± 6.2), phosphatidylethanolamine PE (30.5% ± 3.8), Glc<sub>2</sub>DAG (9.6% ± 4.7) and lysylphosphatidylglycerol (LysPGol, 7.8% ± 3.7) produced by MprF (<xref ref-type="bibr" rid="R83">83</xref>). Recently, L- and N-succinyl-LysPGol, and also L- and D-AlaPGol were identified in <italic>B. subtilis</italic> (<xref ref-type="bibr" rid="R25">25</xref>). Grey arrow indicates a reaction step that might be bidirectional.</p></caption><graphic xlink:href="EMS154565-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>MprF alters cell viability of <italic>B. subtilis</italic> class A PBPs and <italic>mbl</italic> mutants.</title><p><bold>(A)</bold> Ten-fold spot growth assays of strains <italic>B. subtilis</italic> wild type 168CA, AG157 (<italic>ΔponA ΔpbpD ΔpbpF ΔpbpG</italic> renamed <italic>Δ4</italic>), AG223 (<italic>Δ4 ΔmprF</italic>), SWA11a (<italic>ΔponA ΔpbpD ΔpbpF mprF::TnYLB-1 lacA</italic>), AG417 (<italic>ΔpbpD ΔpbpF ΔpbpG</italic> renamed <italic>Δ3</italic>), RE101 (<italic>ΔponA</italic>), AG193 (<italic>ΔponA ΔmprF)</italic> and AG181 (<italic>ΔmprF</italic>). Plates (here glucose 1%) were incubated at 37°C for 24 h and images taken.</p><p><bold>(B)</bold> The effect of <italic>mprF</italic> overexpression (MprF ↑) is assay in different strain backgrounds using an IPTG-inducible <italic>mprF</italic> construct. Plates (here glucose 1%) were incubated at 37°C for 24 h and scanned. Strains tested were AG304 (168CA MprF ↑), AG317 (<italic>Δ4</italic> MprF ↑), AG311 (<italic>ΔponA</italic> MprF ↑), AG421 (<italic>Δ3</italic> MprF ↑) and AG322 (<italic>Δmbl</italic> MprF ↑).</p><p><bold>(C)</bold> Phase-contrast and membrane dye (FM5-95) microscopy images of <italic>B. subtilis</italic> 168CA and AG322 (<italic>Δmbl</italic> MprF ↑) strains grown in NB ± IPTG (0.1 mM) to mid-exponential phase at 37°C. Scale bar indicates 5 µm.</p><p><bold>(D-G)</bold> Transmission electron microscopy (TEM) images show cross-sections of (<bold>D</bold>) wild type 168CA, (<bold>E</bold>) AG181 (<italic>ΔmprF)</italic> and (<bold>F-G</bold>) AG304 strain (MprF ↑) grown in nutrient broth (and IPTG for AG304). Arrows indicate abnormal cell wall structures that seem specific to the strain MprF ↑. All images were taken at 15,000x magnification and processed in Fiji with scale bars attached.</p><p>Data information. Strains phenotype was tested at least three times, TEM experiment was carried out one time. Supporting information for this figure is presented in <xref ref-type="supplementary-material" rid="SD1">Fig S1</xref>, <xref ref-type="supplementary-material" rid="SD1">S2AB</xref>.</p></caption><graphic xlink:href="EMS154565-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>LtaS causes cell morphogenesis defect of an all-class A PBP mutant.</title><p><bold>(A)</bold> Absence of <italic>gtaB</italic> or <italic>ugtP</italic> causes severe growth defect in absence of class A PBPs and MprF. Strains were grown exponentially in NB with 20 mM MgS0<sub>4</sub>, then were washed and diluted in NB prior to preparing a 10-fold serial dilution in NB spotting on the NA and NA glucose (0.5%) plates which were incubated at 37°C and imaged after 24 h and 45 h. Strains were also spotted on same media supplemented with 10 mM MgS0<sub>4</sub> to confirm all the strains dilution spots could grow, at 17 h of incubation only <italic>Δ4 ΔgtaB</italic> and <italic>Δ4 ΔugtP</italic> displayed colonies of smaller size at that time point (data not shown). Strains tested: <italic>B. subtilis</italic> wild type (168CA), PG253 (<italic>ΔugtP</italic>), SM08 (<italic>ΔgtaB</italic>), AG157 (<italic>Δ4</italic>), AG290NopLOSS (<italic>Δ4 ΔgtaB</italic>), AG443 (<italic>Δ4 ΔugtP</italic>), AG223 (<italic>Δ4 ΔmprF</italic>), AG636 (<italic>Δ4 ΔmprF ΔgtaB</italic>) and AG632 (<italic>Δ4 ΔmprF ΔugtP</italic>).</p><p><bold>(B)</bold> Spot dilution growth assays for the following strains: <italic>B. subtilis</italic> wild type 168CA, AG157 (<italic>Δ4</italic>), AG342 (<italic>Δ4 ΔltaS</italic>), AG343* (<italic>Δ4 ΔyfnI</italic>), AG344 (<italic>Δ4 ΔyqgS</italic>), AG370 (<italic>Δ4 ΔltaS ΔyfnI</italic>), AG372 (<italic>Δ4 ΔltaS ΔyqgS</italic>), AG377 (<italic>Δ4 ΔyfnI ΔyqgS</italic>) and AG380 (<italic>Δ4 ΔltaS ΔyfnI ΔyqgS</italic>). Samples were inoculated onto NA ± glucose 1% and, incubated at 37°C for 24 h. * This strain was found to pick up suppressor mutations more rapidly than AG342.</p><p><bold>(C)</bold> Ten-fold serial dilutions were prepared for <italic>B. subtilis</italic> wild type 168CA, AG223 (<italic>Δ4 ΔmprF</italic>), AG389 (AG223 <italic>ΔltaS ΔyqgS</italic>), AG390 (AG223 <italic>ΔyfnI ΔyqgS</italic>), AG399 (AG223 <italic>ΔltaS ΔyfnI</italic>) and AG400 (AG223 <italic>ΔyqgS ΔltaS ΔyfnI</italic>) strains. Plates (here glucose 1%) were incubated at 37°C and imaged after 24h.</p><p><bold>(D)</bold> Representative microscopy images of cells of strains of (A) grown in NB at 37°C for 120 min and stained with a FM5-95 dye. Scale bar represents 5 µm. The average of cells diameter extracted from <xref ref-type="table" rid="T4">Table 4</xref> is indicated. * The cells measurement was done on the straight regions of the cell chain.</p><p>Data information: Strains phenotype was tested at least three times. Supporting information is presented in <xref ref-type="supplementary-material" rid="SD1">Fig S2C</xref>, <xref ref-type="supplementary-material" rid="SD1">S3</xref> which also display results obtained in <italic>ΔponA</italic> background.</p></caption><graphic xlink:href="EMS154565-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Analysis of lipoteichoic acid production in <italic>B. subtilis</italic> strains.</title><p>For each set of cultures (NB ± Glucose 0.2%), samples were separated on the same Bis-Tris gradient gel. Membrane was split at ~ 60 kDa position. The lower part of the membrane was probed using a monoclonal antibody for Gram-positive LTA and an HRP-linked anti-mouse antibody. The other membrane part was probed using polyclonal anti-PBP2B and HRP-linked anti-rabbit antibodies, to provide a sample loading control.</p><p><bold>(A)</bold> Samples were prepared from strains <italic>B. subtilis</italic> wild type (168CA), 4285CA (<italic>ΔltaS</italic>), 4289CA (<italic>ΔyfnI</italic>), 4292CA (<italic>ΔyqgS</italic>), AG595 (<italic>ΔyfnI ΔyqgS</italic>), AG593 (<italic>ΔltaS ΔyqgS</italic>), AG594 (<italic>ΔltaS ΔyfnI</italic>), AG600 (<italic>ΔltaS ΔyfnI ΔyqgS</italic>) and 4620 (<italic>ΔltaS ΔyfnI ΔyqgS ΔyvgJ</italic>, noted here ΔLTA).</p><p><bold>(B)</bold> Strains analysed: <italic>B. subtilis</italic> 168CA, AG417 (<italic>ΔpbpD ΔpbpF ΔpbpG</italic>), RE101 (<italic>ΔponA</italic>), AG181 (<italic>ΔmprF</italic>), AG193 (<italic>ΔponA ΔmprF</italic>), AG304 (MprF ↑), AG311 (<italic>ΔponA</italic> MprF ↑), 4261CA <italic>(Δmbl)</italic>, AG322 <italic>(Δmbl</italic> MprF ↑). A densitometry graph of the left blot is presented in <xref ref-type="supplementary-material" rid="SD1">Fig S5D</xref>.</p><p><bold>(C)</bold> Samples were extracted from <italic>B. subtilis</italic> 168CA, 4285CA (<italic>ΔltaS</italic>), AG383 (<italic>ΔltaS ΔponA</italic>), PG253 (<italic>ΔugtP</italic>) and AG444 (<italic>ΔugtP ΔponA</italic>) strains.</p><p>Data information: Representative of one of three independent experiments shown in <xref ref-type="supplementary-material" rid="SD1">Fig S4-S6</xref>. At each section A, B, C, samples were derived from the same experiment.</p></caption><graphic xlink:href="EMS154565-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>LytE overexpression is conditionally lethal in absence of PBP1 or LtaS.</title><p><bold>(A)</bold> <italic>lytE</italic> overexpression was analysed in strains which integrated at the <italic>amyE</italic> locus an (0.1 mM) IPTG-inducible <italic>P<sub>hyspank</sub>-lytE</italic>, represented here LytE ↑. The strains tested had the following relevant features: AG484 (<italic>ΔponA</italic> LytE ↑), AG1460 (<italic>Δ3 ponA<sup>+</sup></italic> LytE ↑), AG501 (<italic>Δ4</italic> LytE ↑), AG502 (<italic>Δ4 ΔmprF</italic> LytE ↑), AG1465 (<italic>Δ4 ΔltaS</italic> LytE ↑), AG1478 (<italic>ΔmprF</italic> LytE ↑), AG1479 (<italic>ΔponA ΔmprF</italic> LytE ↑), AG1462 (<italic>ΔltaS</italic> LytE ↑), AG1480 (<italic>ΔponA ΔltaS</italic> LytE ↑), AG1497 (<italic>ΔltaS ΔyfnI</italic> LytE ↑), AG1498 (<italic>ΔltaS ΔyqgS</italic> LytE ↑) and AG1499 (<italic>ΔyqgS ΔyfnI</italic> LytE ↑). The following strains that did not display any obvious phenotype are not represented here: AG475 (168CA LytE ↑), AG1461 (<italic>ΔlytE</italic> LytE ↑), AG1463 (<italic>ΔyfnI</italic> LytE ↑), AG1492 (<italic>ΔyqgS</italic> LytE ↑). Plates (here glucose 0.5%) were incubated at 37°C and scanned after 24 h (this figure) and 48 h (<xref ref-type="supplementary-material" rid="SD1">Fig S7A</xref>).</p><p><bold>(B)</bold> Strains AG1481 (<italic>ΔmprF</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic>) and AG551 (168CA pLOSS-<italic>P<sub>spac</sub>-lytE</italic>) were streaked on NA and NA glucose (0.5%), supplemented with IPTG (1 mM) and X-Gal from a fresh colony on NA spectinomycin. Plates were incubated at 37°C and scanned after 24 h. Blue colonies indicate the stabilisation of plasmid pLOSS-<italic>P<sub>spac</sub>-lytE</italic> in <italic>ΔmprF</italic>. Grey scale images are here to help visualize white colonies.</p><p><bold>(C)</bold> Detection of LytE-His<sub>12</sub> and PBP2B by Western blots. For simplification on this figure only the relevant background feature is displayed for the following strains (expressing LytE-His<sub>12</sub> under the control of its native promoter): wild-type-like AG565 (WT*), AG587 (<italic>ΔponA</italic>), AG1486 (<italic>ΔmprF</italic>), AG1487 (<italic>ΔponA ΔmprF</italic>), AG1489 (<italic>ΔltaS</italic>), AG1488 (<italic>ΔponA ΔltaS</italic>), AG1535 (<italic>ΔugtP</italic>) and AG1541 (<italic>ΔcwlO</italic>). In addition, <italic>B. subtilis</italic> 168CA was grown in parallel (without antibiotic) and used here as a negative control for the LytE-blot. The membrane was split and incubated either with a monoclonal Penta-His and an HRP-linked anti-mouse antibodies or with a polyclonal anti-PBP2B and HRP-linked anti-rabbit antibodies. Note: a ‘ladder’ sample loaded after the NB-Glucose (0.2%) sample set is not displayed and the image editing is symbolised by the vertical black line (see original on <xref ref-type="supplementary-material" rid="SD1">Fig S7B</xref>, middle panel).</p><p><bold>(D)</bold> Detection of LTA-synthases LtaS/YfnI and PBP2B by Western blots. The samples used in experiment <bold>C</bold> were loaded on a new SDS-gel and the Western blot was carry out with polyclonal anti-LtaS (able to detect YfnI, unpublished Errington’s lab), anti-PBP2B antibodies, and HRP-linked anti-rabbit antibodies.</p><p>Data information: One representative set of three independent Western Blot experiments is shown here and in <xref ref-type="supplementary-material" rid="SD1">Fig S7B</xref>, <xref ref-type="supplementary-material" rid="SD1">S8A</xref>. Additional supporting information is presented in <xref ref-type="supplementary-material" rid="SD1">Fig S8</xref>, <xref ref-type="supplementary-material" rid="SD1">S9</xref>. At each section samples were derived from the same experiment.</p></caption><graphic xlink:href="EMS154565-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Daptomycin resistance and LTA synthesis in <italic>B. subtilis</italic> and <italic>S. aureus</italic>.</title><p><bold>(A)</bold> Samples of methicillin-sensitive <italic>Staphylococcus aureus</italic> strains SA113 and SA113 <italic>ΔmprF</italic> (<xref ref-type="bibr" rid="R21">21</xref>) were probed for LTA by Western Blot.</p><p><bold>(B)</bold> Researchers identified that a modified allele of <italic>pgsA</italic>(<italic>A64V</italic>) was the major determinant of daptomycin resistance of <italic>B. subtilis</italic> Dap<sup>R</sup>1 and Dap<sup>R</sup>20 strains selected by serial daptomycin antibiotic passages (<xref ref-type="bibr" rid="R54">54</xref>). The strains 168 1A1 (wild type, WT), Dap<sup>R</sup>1, Dap<sup>R</sup>20, HB15516 (Dap<sup>R</sup>1 <italic>pgsA</italic><sup>WT</sup>) and HB15507 (Dap<sup>R</sup>20 <italic>pgsA</italic><sup>WT</sup>) were grown in NB overnight at 30°C and LTA was detected (top panel) along with PBP2B (middle panel) by Western Blots. Analysis of the samples grown exponentially at 37°C using theses overnight cultures is presented in <xref ref-type="supplementary-material" rid="SD1">Fig S10F</xref>. The bottom panel shows the cellular abundance of the LTA-synthase detected with an anti-LtaS (that also cross reacts with YfnI, unpublished Errington’s lab). Here the samples were normalized based on the previous PBP2B blot (middle panel) (blotted as in <xref ref-type="fig" rid="F5">Fig 5D</xref>).</p><p>Data information: One representative set of three experiments is shown here and in <xref ref-type="supplementary-material" rid="SD1">Fig S10F</xref>.</p><p><bold>(C)</bold> Absence of LTA-synthase LtaS increase <italic>B. subtilis</italic> susceptibility to daptomycin. Dap strip assays (Liofilchem) on NA-CaCl<sub>2</sub> plates were carried out on <italic>B. subtilis</italic> wild type (168CA), AG600 (<italic>ΔltaS ΔyfnI ΔyqgS</italic>, noted no LTA), AG593 (<italic>ΔltaS ΔyqgS</italic>), AG594 (<italic>ΔltaS ΔyfnI</italic>), AG595 (<italic>ΔyfnI ΔyqgS</italic>, noted LtaS-only), AG1673 (<italic>ΔltaS ΔyqgS ΔmprF</italic>), AG1675 (<italic>ΔyfnI ΔyqgS ΔmprF</italic>) and AG1663 (<italic>ΔmprF</italic>) strains. Plates were incubated at 37°C and scanned after 24h (illustrations on top panel). * The table represents the average of at least two independent experiments except for <italic>ΔmprF</italic>.</p><p>Data information: Additional supporting information is presented in <xref ref-type="supplementary-material" rid="SD1">Fig S10</xref></p></caption><graphic xlink:href="EMS154565-f006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><title>A summary of the alteration in LTA and LytE levels associated with the conditional lethality of <italic>ΔltaS</italic> and <italic>ΔponA</italic> mutants.</title><p><bold>(A)</bold> The overexpression of <italic>lytE</italic> (inducible) in the double LTA-synthase mutants is lethal except when the major LTA synthase LtaS is functional. The presence of a distinct LTA length is presented by the mutant strains (<xref ref-type="fig" rid="F4">Fig 4A</xref>, <xref ref-type="fig" rid="F5">5A</xref>).</p><p><bold>(B)</bold> In glucose, the viability and lethality of mutants in <italic>ΔponA</italic> background were associated to distinct LTA, LytE and LtaS/YfnI levels (<xref ref-type="fig" rid="F2">Fig 2A-B</xref>, <xref ref-type="fig" rid="F3">3A</xref>, <xref ref-type="fig" rid="F4">4B-C</xref>, <xref ref-type="fig" rid="F5">5A, C-D</xref>). * The overexpression of <italic>lytE</italic> (inducible) is lethal to <italic>ΔponA</italic> but not to <italic>ΔponA ΔmprF</italic> mutant (<xref ref-type="fig" rid="F5">Fig 5A</xref>). Strains with the ability to grow without significant cell lysis are referred as viable (green text in the cell). Lethal refers to an absence of growth of the mutant on NA or in the specified condition (dashed rod cell, with red text). In these cases, analysis of the strains was done by shifting cultures to non-permissive conditions (e.g. low magnesium, addition of glucose or inducer). Arrows indicate an increase (↑) or decrease (↓) of the specified factor. Here it is assumed that the strength of LTA signal observed by Western blot is proportional to abundance.</p></caption><graphic xlink:href="EMS154565-f007"/></fig><fig id="F8" position="float"><label>Figure 8</label><caption><title>Figure 8. MprF positively regulates the synthesis of LTA in <italic>B. subtilis</italic> and <italic>S. aureus</italic></title><p>(<bold>A</bold>) MprF or its substrates positively regulate LTA production in <italic>B. subtilis</italic> and in <italic>S. aureus</italic>.</p><p>(<bold>B</bold>) Proposed role of MprF in LTA production via its substrate aminoacyl-phosphatidylglycerols (aaPGol) (not limitative). (<bold>1</bold>) LtaS could use the aminoacyl-glycerol-phosphate (aaGroP) of aaPGol as a last LTA capping unit. Potentially the addition of this positive charged capping unit (e.g. lysyl, alanylGroP) could contribute to the protection against CAMPs. (<bold>2-3</bold>) MprF could indirectly alters LtaS processivity: the release of the aminoacyl could permit LtaS to use the PGol as lipid anchor (<bold>2</bold>), the presence of aaPGol in the vicinity of LtaS could create an electrostatic environment that help maintain the growing LTA chain in a conformation that favors LtaS processing (<bold>3</bold>).</p></caption><graphic xlink:href="EMS154565-f008"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Plasmids used in this study</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle">Plasmids</th><th align="left" valign="middle">Relevant features<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></th><th align="left" valign="middle">Source or reference</th></tr></thead><tbody><tr><td align="left" valign="middle">pAM-21</td><td align="left" valign="middle"><italic>kan P<sub>T7</sub></italic> LytE<sup>(26-334AA)</sup>-6His <italic>lacI</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pCotC-GFP</td><td align="left" valign="middle">used as matrix to amplify <italic>cat</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R75">75</xref>)</td></tr><tr><td align="left" valign="middle">pDR111</td><td align="left" valign="middle"><italic>bla amyE::(lacI P<sub>hyspank</sub>, spc)</italic></td><td align="left" valign="middle">Rudner, D., unpublished</td></tr><tr><td align="left" valign="middle">pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>ltaS</italic></td><td align="left" valign="middle"><italic>bla amyE::(lacI P<sub>hyspank</sub>-ltaS, spc)</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>mprF</italic></td><td align="left" valign="middle"><italic>bla amyE::(lacI P<sub>hyspank-ATG</sub>mprF, spc)</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>yfnI</italic></td><td align="left" valign="middle"><italic>bla amyE::(lacI P<sub>hyspank</sub>-yfnI, spc)</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pDR111-<italic>P<sub>hyspank</sub></italic>-<italic>yqgS</italic></td><td align="left" valign="middle"><italic>bla amyE::(lacI P<sub>hyspank</sub>-yqgS, spc)</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pET28a (+)</td><td align="left" valign="middle"><italic>kan P<sub>T7</sub> his lacI</italic></td><td align="left" valign="middle">Novagen</td></tr><tr><td align="left" valign="middle">pG+host9::<italic>ΔponA</italic></td><td align="left" valign="middle"><italic>erm</italic>, carry flanking DNA regions of <italic>ponA</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R12">12</xref>)</td></tr><tr><td align="left" valign="middle">pG+host10::<italic>ΔpbpD</italic></td><td align="left" valign="middle"><italic>bla</italic>, carry flanking DNA regions of <italic>pbpD</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R12">12</xref>)</td></tr><tr><td align="left" valign="middle">pG+host10::<italic>ΔpbpF</italic></td><td align="left" valign="middle"><italic>bla</italic>, carry flanking DNA regions of <italic>pbpF</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R12">12</xref>)</td></tr><tr><td align="left" valign="middle">pIC22</td><td align="left" valign="middle">used as matrix to amplify <italic>phleo</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R76">76</xref>)</td></tr><tr><td align="left" valign="middle">pLOSS*</td><td align="left" valign="middle"><italic>bla spc P<sub>spac</sub>-mcs P<sub>divIVA-</sub>lacZ lacI rep<sub>pLS20</sub>(GA</italic>→<italic>CC</italic>)</td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R39">39</xref>)</td></tr><tr><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub></italic>-<italic>lytE</italic></td><td align="left" valign="middle"><italic>bla spc P<sub>spac</sub>-lytE P<sub>divIVA</sub>-lacZ lacI rep<sub>pLS20</sub>(GA→CC)</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub></italic>-<italic>ponA</italic></td><td align="left" valign="middle"><italic>bla spc P<sub>spac</sub>-ponA P<sub>divIVA</sub>-lacZ lacI rep<sub>pLS20</sub>(GA→CC)</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R12">12</xref>)</td></tr><tr><td align="left" valign="middle">pMarB</td><td align="left" valign="middle"><italic>bla erm</italic> TnYLB-1::<italic>kan Himar1</italic> transposase</td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R77">77</xref>)</td></tr><tr><td align="left" valign="middle">pMUTinHis</td><td align="left" valign="middle"><italic>bla erm P<sub>spac</sub> mcs 12xhis lacZ lacI</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R73">73</xref>)</td></tr><tr><td align="left" valign="middle">pMUTin-<italic>`lytE-his</italic></td><td align="left" valign="middle"><italic>bla erm P<sub>spac</sub> mcs `</italic>LytE-6AA-12His <italic>lacZ lacI</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pMUTin-<italic>`ltaS-his</italic></td><td align="left" valign="middle"><italic>bla erm P<sub>spac</sub> mcs `</italic>LtaS-6AA-12His <italic>lacZ lacI</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">pMUTin-<italic>`yfnI-his</italic></td><td align="left" valign="middle"><italic>bla erm P<sub>spac</sub> mcs `</italic>YfnI-6AA-12His <italic>lacZ lacI</italic></td><td align="left" valign="middle">This study</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p id="P74"><italic>cat</italic>, chloramphenicol resistance; <italic>bla</italic>, ampicillin resistance; <italic>spc</italic>, spectinomycin resistance; <italic>erm</italic>, erythromycin resistance; <italic>phleo</italic>, phleomycin resistance; <italic>kan</italic>, kanamycin resistance; <italic>lacI</italic>, encodes lactose repressor; <italic>mcs</italic>, multiple cloning site; <italic>lacZ</italic>, encodes β-galactosidase; AA, amino acids; <italic>P<sub>hyspank</sub></italic> and <italic>P<sub>spac</sub></italic> are IPTG-inducible promoters with <italic>P<sub>hyspank</sub></italic> known to be stronger; <italic>rep<sub>pLS20</sub>(GA→CC)</italic>, unstable replication in <italic>Bacillus</italic>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Strains used in this study</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle"><bold>Strains</bold></th><th align="left" valign="middle"><bold>Relevant genotype<sup><xref ref-type="table-fn" rid="TFN2">a</xref></sup></bold></th><th align="left" valign="middle"><bold>Source or reference<sup><xref ref-type="table-fn" rid="TFN3">b</xref></sup></bold></th></tr></thead><tbody><tr><td align="left" valign="middle"><italic><bold>E. coli</bold></italic></td><td align="left" valign="middle"> </td><td align="left" valign="middle"> </td></tr><tr><td align="left" valign="middle">DH5α</td><td align="left" valign="middle">F<sup>-</sup> endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80d<italic>lacZ</italic>ΔM15 Δ(<italic>lacZYA-argF</italic>)U169, hsdR17(r<sub>K</sub><sup>-</sup> m<sub>K</sub><sup>+</sup>), λ–</td><td align="left" valign="middle">Lab. stock</td></tr><tr><td align="left" valign="middle">BL21(DE3)</td><td align="left" valign="middle">B F<sup>–</sup> <italic>ompT gal dcm lon hsdS<sub>B</sub></italic>(<italic>r<sub>B</sub></italic><sup>–</sup><italic>m<sub>B</sub></italic><sup>–</sup>) λ(DE3 [<italic>lacI lacUV5</italic>-<italic>T7p07 ind1 sam7 nin5</italic>]) [<italic>malB</italic><sup>+</sup>]<sub>K-12</sub>(λ<sup>S</sup>)</td><td align="left" valign="middle">Novagen</td></tr><tr><td align="left" valign="middle"><italic><bold>B. subtilis</bold></italic></td><td align="left" valign="middle"> </td><td align="left" valign="middle"> </td></tr><tr><td align="left" valign="middle">168CA</td><td align="left" valign="middle"><italic>trpC2</italic></td><td align="left" valign="middle">R. Daniel Lab. stock</td></tr><tr><td align="left" valign="middle">168 1A1</td><td align="left" valign="middle"><italic>trpC2</italic> (BGSC n° 1A1)</td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R54">54</xref>)</td></tr><tr><td align="left" valign="middle">3725CA</td><td align="left" valign="middle"><italic>trpC2 Ωneo ΔmreB</italic></td><td align="left" valign="middle">3725 (<xref ref-type="bibr" rid="R78">78</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4261CA</td><td align="left" valign="middle"><italic>trpC2 Δmbl::cat</italic></td><td align="left" valign="middle">4261 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4283CA</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::neo</italic></td><td align="left" valign="middle">4283 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4285CA</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat</italic></td><td align="left" valign="middle">4285 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4287CA</td><td align="left" valign="middle"><italic>trpC2 ΔyfnI::spc</italic></td><td align="left" valign="middle">4287 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4289CA</td><td align="left" valign="middle"><italic>trpC2 ΔyfnI::erm</italic></td><td align="left" valign="middle">4289 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4292CA</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::spc</italic></td><td align="left" valign="middle">4292 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4293CA</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat</italic></td><td align="left" valign="middle">4293 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4294CA</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::erm</italic></td><td align="left" valign="middle">4294 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4295CA</td><td align="left" valign="middle"><italic>trpC2 ΔyvgJ::spc</italic></td><td align="left" valign="middle">4295 (<xref ref-type="bibr" rid="R79">79</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">4620</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::neo ΔyfnI::cat ΔyqgS::spc ΔyvgJ::erm</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R79">79</xref>)</td></tr><tr><td align="left" valign="middle">AG105</td><td align="left" valign="middle"><italic>trpC2 ΔpbpD ΔpbpF</italic></td><td align="left" valign="middle">pGhost10::ΔpbpF (<xref ref-type="bibr" rid="R12">12</xref>) → RE103 cells</td></tr><tr><td align="left" valign="middle">AG108</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF</italic></td><td align="left" valign="middle">pG<sup>+</sup>host10::<italic>ΔpbpF</italic> → RE104 cells</td></tr><tr><td align="left" valign="middle">AG123</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF</italic> pLOSS-<italic>P<sub>spac</sub>-ponA</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-ponA</italic> → AG108 cells</td></tr><tr><td align="left" valign="middle">AG141</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF</italic> pLOSS-<italic>P<sub>spac</sub>-ponA lacA::cat</italic></td><td align="left" valign="middle">K532 → AG123 cells</td></tr><tr><td align="left" valign="middle">AG157</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R12">12</xref>)</td></tr><tr><td align="left" valign="middle">AG181</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::phleo</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">AG185</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::phleo Ωneo ΔmreB</italic></td><td align="left" valign="middle">3725CA → AG181 cells</td></tr><tr><td align="left" valign="middle">AG189</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::phleo Δmbl::cat</italic></td><td align="left" valign="middle">4261CA → AG181 cell</td></tr><tr><td align="left" valign="middle">AG193</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔmprF::phleo</italic></td><td align="left" valign="middle">AG181 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG200</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF</italic> pLOSS-<italic>P<sub>spac</sub>-ponA ΔmprF::phleo lacA::cat</italic></td><td align="left" valign="middle">AG181 → AG141 cells</td></tr><tr><td align="left" valign="middle">AG200BK#42</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF</italic> pLOSS-<italic>P<sub>spac</sub>-ponA ΔmprF::phleo lacA::cat gtaB::</italic>TnYLB-1<italic>(kan)</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">AG210</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo lacA::cat</italic> pLOSS-<italic>P<sub>spac</sub>-ponA</italic></td><td align="left" valign="middle">DPVB45CA → AG200 cells</td></tr><tr><td align="left" valign="middle">AG211</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan</italic> pLOSS-<italic>P<sub>spac</sub>-ponA</italic></td><td align="left" valign="middle">DPVB45CA → AG123 cells</td></tr><tr><td align="left" valign="middle">AG223</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo</italic></td><td align="left" valign="middle">AG181 → AG157 cells</td></tr><tr><td align="left" valign="middle">AG290</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan</italic> pLOSS-<italic>P<sub>spac</sub>-ponA ΔgtaB::erm</italic></td><td align="left" valign="middle">SM08 → AG211 cells</td></tr><tr><td align="left" valign="middle">AG290NopLoss</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔgtaB::erm</italic></td><td align="left" valign="middle">AG290 lost plasmid on 20 mM MgS0<sub>4</sub> with kan</td></tr><tr><td align="left" valign="middle">AG292</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan</italic> pLOSS-<italic>P<sub>spac</sub>-ponA Ωerm ΔtagE</italic></td><td align="left" valign="middle">SM50 → AG211 cells</td></tr><tr><td align="left" valign="middle">AG293</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ggaAB::spc</italic></td><td align="left" valign="middle">SM31 → AG229 cells</td></tr><tr><td align="left" valign="middle">AG296</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan</italic> pLOSS-<italic>P<sub>spac</sub>-ponA pgcA::tet</italic></td><td align="left" valign="middle">SSB122 → AG211 cells</td></tr><tr><td align="left" valign="middle">AG304</td><td align="left" valign="middle"><italic>trpC2 amyE::(Physpank -mprF, spc)</italic></td><td align="left" valign="middle">pDR111-<italic>P<sub>hyspank</sub>-mprF</italic> → 168CA cells</td></tr><tr><td align="left" valign="middle">AG311</td><td align="left" valign="middle"><italic>trpC2 ΔponA amyE::(Physpank -mprF, spc)</italic></td><td align="left" valign="middle">AG304 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG317</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan amyE::(P<sub>hyspank</sub>-mprF, spc)</italic></td><td align="left" valign="middle">AG304 → AG157 cells</td></tr><tr><td align="left" valign="middle">AG322</td><td align="left" valign="middle"><italic>trpC2 amyE::(P<sub>hyspank</sub>-mprF, spc) Δmbl::cat</italic></td><td align="left" valign="middle">4261CA → AG304 cells</td></tr><tr><td align="left" valign="middle">AG327</td><td align="left" valign="middle"><italic>trpC2 amyE::(P<sub>hyspank</sub>-mprF, spc) Ωneo ΔmreB</italic></td><td align="left" valign="middle">3725CA → AG304 cells</td></tr><tr><td align="left" valign="middle">AG341</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan dltAB::cat</italic></td><td align="left" valign="middle">DLT71 (<xref ref-type="bibr" rid="R40">40</xref>) → AG157 cells</td></tr><tr><td align="left" valign="middle">AG342</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔltaS::cat</italic></td><td align="left" valign="middle">4285CA → AG157 cells</td></tr><tr><td align="left" valign="middle">AG343</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔyfnI::erm</italic></td><td align="left" valign="middle">4289CA → AG157 cells</td></tr><tr><td align="left" valign="middle">AG344</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔyqgS::erm</italic></td><td align="left" valign="middle">4294CA→ AG157 cells</td></tr><tr><td align="left" valign="middle">AG347</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::phleo ΔltaS::cat</italic></td><td align="left" valign="middle">4285CA → AG181 cells</td></tr><tr><td align="left" valign="middle">AG349</td><td align="left" valign="middle"><italic>trpC2 amyE::(P<sub>hyspank</sub>-mprF, spc) ΔltaS::cat</italic></td><td align="left" valign="middle">4285CA → AG304 cells</td></tr><tr><td align="left" valign="middle">AG353</td><td align="left" valign="middle"><italic>trpC2 amyE::(P<sub>hyspank</sub>-mprF, spc) ΔyfnI::erm</italic></td><td align="left" valign="middle">4289CA→ AG304 cells</td></tr><tr><td align="left" valign="middle">AG370</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔltaS::cat ΔyfnI::erm</italic></td><td align="left" valign="middle">4289CA → AG342 cells</td></tr><tr><td align="left" valign="middle">AG372</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔltaS::cat ΔyqgS::erm</italic></td><td align="left" valign="middle">4294CA → AG342 cells</td></tr><tr><td align="left" valign="middle">AG377</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔyqgS::erm ΔyfnI::spc</italic></td><td align="left" valign="middle">4287CA → AG344 cells</td></tr><tr><td align="left" valign="middle">AG380</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔltaS::cat ΔyqgS::erm ΔyfnI::spc</italic></td><td align="left" valign="middle">4287CA → AG372 cells</td></tr><tr><td align="left" valign="middle">AG383</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat</italic></td><td align="left" valign="middle">4285CA → RE101 cells</td></tr><tr><td align="left" valign="middle">AG384</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔyfnI::erm</italic></td><td align="left" valign="middle">4289CA → RE101 cells</td></tr><tr><td align="left" valign="middle">AG385</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔyqgS::spc</italic></td><td align="left" valign="middle">4292CA → RE101 cells</td></tr><tr><td align="left" valign="middle">AG389</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo ΔltaS::cat ΔyqgS::erm</italic></td><td align="left" valign="middle">AG223 → AG372 cells</td></tr><tr><td align="left" valign="middle">AG390</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo ΔygqS::erm ΔyfnI::spc</italic></td><td align="left" valign="middle">AG223 → AG377 cells</td></tr><tr><td align="left" valign="middle">AG393</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat ΔyfnI::erm</italic></td><td align="left" valign="middle">4289CA → AG383 cells</td></tr><tr><td align="left" valign="middle">AG394</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat ΔyqgS::spc</italic></td><td align="left" valign="middle">4292CA → AG383 cells</td></tr><tr><td align="left" valign="middle">AG395</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔyfnI::spc ΔyqgS::spc</italic></td><td align="left" valign="middle">4292CA→ AG384 cells</td></tr><tr><td align="left" valign="middle">AG399</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo ΔltaS::cat ΔyfnI::erm</italic></td><td align="left" valign="middle">AG223 → AG370 cells</td></tr><tr><td align="left" valign="middle">AG400</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo ΔltaS::cat ΔyqgS::erm ΔyfnI::spc</italic></td><td align="left" valign="middle">AG223 → AG380 cells</td></tr><tr><td align="left" valign="middle">AG403</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat ΔyfnI::erm ΔyqgS::spc</italic></td><td align="left" valign="middle">4292CA → AG393 cells</td></tr><tr><td align="left" valign="middle">AG417</td><td align="left" valign="middle"><italic>trpC2 ΔpbpD ΔpbpF ΔpbpG::kan</italic></td><td align="left" valign="middle">DPVB45CA → AG105 cells</td></tr><tr><td align="left" valign="middle">AG421</td><td align="left" valign="middle"><italic>trpC2 ΔpbpD ΔpbpF ΔpbpG::kan amyE::(Physpank mprF, spc)</italic></td><td align="left" valign="middle">AG304 → AG417 cells</td></tr><tr><td align="left" valign="middle">AG441</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat ΔyfnI::erm ΔugtP::spc</italic></td><td align="left" valign="middle">PG253 → AG393 cells</td></tr><tr><td align="left" valign="middle">AG442</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat ΔyfnI::erm gtaB::TnYLB-1(kan)</italic></td><td align="left" valign="middle">AG200BK#42 → 168CA → AG393 cells</td></tr><tr><td align="left" valign="middle">AG443</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔugtP::spc</italic></td><td align="left" valign="middle">PG253 → AG157 cells</td></tr><tr><td align="left" valign="middle">AG444</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔugtP::spc</italic></td><td align="left" valign="middle">PG253 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG474</td><td align="left" valign="middle"><italic>trpC2 ΔcwlO::spc</italic></td><td align="left" valign="middle">PDC463 (<xref ref-type="bibr" rid="R43">43</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">AG475</td><td align="left" valign="middle"><italic>trpC2 amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">Dominguez-Cuevas, unpublished → 168CA cells</td></tr><tr><td align="left" valign="middle">AG484</td><td align="left" valign="middle"><italic>trpC2 ΔponA amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG501</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG157 cells</td></tr><tr><td align="left" valign="middle">AG502</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG223 cells</td></tr><tr><td align="left" valign="middle">AG506</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔgtaB::erm</italic></td><td align="left" valign="middle">SM08 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG547</td><td align="left" valign="middle"><italic>trpC2 ΔlytE::cat</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle">AG549</td><td align="left" valign="middle"><italic>trpC2 ΔlytE::cat</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> →AG547 cells</td></tr><tr><td align="left" valign="middle">AG551</td><td align="left" valign="middle"><italic>trpC2</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → 168CA cells</td></tr><tr><td align="left" valign="middle">AG557</td><td align="left" valign="middle"><italic>trpC2 ΔponA</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → RE101 cells</td></tr><tr><td align="left" valign="middle">AG565</td><td align="left" valign="middle"><italic>trpC2 ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">pMUTinHis-<italic>'lytE</italic> → 168CA cells</td></tr><tr><td align="left" valign="middle">AG569</td><td align="left" valign="middle"><italic>trpC2 ΩltaS-his<sub>12</sub>::(</italic>pMUTIN-`<italic>ltaS, erm)</italic></td><td align="left" valign="middle">pMUTinHis-<italic>'ltaS</italic> → 168CA cells</td></tr><tr><td align="left" valign="middle">AG570</td><td align="left" valign="middle"><italic>trpC2 ΩyfnI-his<sub>12</sub>::(</italic>pMUTIN-`<italic>yfnI, erm)</italic></td><td align="left" valign="middle">pMUTinHis-<italic>'yfnI</italic> → 168CA cells</td></tr><tr><td align="left" valign="middle">AG586</td><td align="left" valign="middle"><italic>trpC2 ΔcwlO::spc ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE</italic>,</td></tr><tr><td align="left" valign="middle"><italic>erm</italic>)</td><td align="left" valign="middle">pMUTinHis-<italic>'lytE</italic> → AG474 cells</td></tr><tr><td align="left" valign="middle">AG587</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">AG565 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG588</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΩltaS-his<sub>12</sub>::(</italic>pMUTIN<italic>-`ltaS, erm)</italic></td><td align="left" valign="middle">AG569 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG589</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΩyfnI-his<sub>12</sub>::(</italic>pMUTIN<italic>-`yfnI, erm)</italic></td><td align="left" valign="middle">AG570 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG593</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS:spc ΔltaS::cat</italic></td><td align="left" valign="middle">4292CA → 4285CA cells</td></tr><tr><td align="left" valign="middle">AG594</td><td align="left" valign="middle"><italic>trpC2 ΔyfnI::erm ΔltaS::cat</italic></td><td align="left" valign="middle">4289CA → 4285CA cells</td></tr><tr><td align="left" valign="middle">AG595</td><td align="left" valign="middle"><italic>trpC2 ΔyfnI::erm ΔyqgS::spc</italic></td><td align="left" valign="middle">4292CA → 4289CA cells</td></tr><tr><td align="left" valign="middle">AG600</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyfnI::erm ΔyqgS::spc</italic></td><td align="left" valign="middle">4285CA → AG595 cells</td></tr><tr><td align="left" valign="middle">AG614</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo</italic> pLOSS-<italic>P<sub>spac</sub>-ponA ΔgtaB::erm</italic></td><td align="left" valign="middle">SM08 → AG210 cells</td></tr><tr><td align="left" valign="middle">AG632</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo ΔugtP::spc</italic></td><td align="left" valign="middle">PG253 → AG223 cells</td></tr><tr><td align="left" valign="middle">AG636</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔmprF::phleo ΔgtaB::erm</italic></td><td align="left" valign="middle">AG614 plasmid lost on NA MgS0<sub>4</sub> 20 mM with erm</td></tr><tr><td align="left" valign="middle">AG1460</td><td align="left" valign="middle"><italic>trpC2 ΔpbpD ΔpbpF ΔpbpG::kan amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG417 cells</td></tr><tr><td align="left" valign="middle">AG1461</td><td align="left" valign="middle"><italic>trpC2 ΔlytE::cat amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG547 cells</td></tr><tr><td align="left" valign="middle">AG1462</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → 4285CA cells</td></tr><tr><td align="left" valign="middle">AG1463</td><td align="left" valign="middle"><italic>trpC2 ΔyfnI::erm amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → 4289CA cells</td></tr><tr><td align="left" valign="middle">AG1465</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF ΔpbpG::kan ΔltaS::cat amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG342 cells</td></tr><tr><td align="left" valign="middle">AG1466</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → 4285CA cells</td></tr><tr><td align="left" valign="middle">AG1467</td><td align="left" valign="middle"><italic>trpC2 ΔyfnI::erm</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → 4289CA cells</td></tr><tr><td align="left" valign="middle">AG1469</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyfnI::erm</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → AG594 cells</td></tr><tr><td align="left" valign="middle">AG1478</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::phleo amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG181 cells</td></tr><tr><td align="left" valign="middle">AG1479</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔmprF::phleo amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG193 cells</td></tr><tr><td align="left" valign="middle">AG1480</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG383 cells</td></tr><tr><td align="left" valign="middle">AG1481</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::phleo</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → AG181 cells</td></tr><tr><td align="left" valign="middle">AG1482</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔmprF::phleo</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → AG193 cells</td></tr><tr><td align="left" valign="middle">AG1483</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → AG383 cells</td></tr><tr><td align="left" valign="middle">AG1486</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::phleo ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">AG565 → AG181 cells</td></tr><tr><td align="left" valign="middle">AG1487</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔmprF::phleo ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">AG565 → AG193 cells</td></tr><tr><td align="left" valign="middle">AG1488</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔltaS::cat ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">AG565 → AG383 cells</td></tr><tr><td align="left" valign="middle">AG1489</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">AG565 → 4285CA cells</td></tr><tr><td align="left" valign="middle">AG1490</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyqgS::erm</italic></td><td align="left" valign="middle">4294CA → 4285CA cells</td></tr><tr><td align="left" valign="middle">AG1491</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat ΔyfnI::erm</italic></td><td align="left" valign="middle">4293CA → 4289CA cells</td></tr><tr><td align="left" valign="middle">AG1492</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → 4293CA cells</td></tr><tr><td align="left" valign="middle">AG1493</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → 4293CA cells</td></tr><tr><td align="left" valign="middle">AG1497</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyfnI::erm amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG594 cells</td></tr><tr><td align="left" valign="middle">AG1498</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyqgS::erm amyE::(P<sub>hyspank-</sub>lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG1490 cells</td></tr><tr><td align="left" valign="middle">AG1499</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat ΔyfnI::erm amyE::(P<sub>hyspank-</sub>lytE, spc)</italic></td><td align="left" valign="middle">AG475 → AG1491 cells</td></tr><tr><td align="left" valign="middle">AG1500</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyqgS::erm</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → AG1490 cells</td></tr><tr><td align="left" valign="middle">AG1502</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat ΔyfnI::erm</italic> pLOSS-<italic>P<sub>spac</sub>-lytE</italic></td><td align="left" valign="middle">pLOSS-<italic>P<sub>spac</sub>-lytE</italic> → AG1491 cells</td></tr><tr><td align="left" valign="middle">AG1535</td><td align="left" valign="middle"><italic>trpC2 ΔugtP::spc ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">AG565 → PG253 cells</td></tr><tr><td align="left" valign="middle">AG1541</td><td align="left" valign="middle"><italic>trpC2 ΔcwlO::spc ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>)</td><td align="left" valign="middle">AG565 → AG474 cells</td></tr><tr><td align="left" valign="middle">AG1581</td><td align="left" valign="middle"><italic>trpC2 Δmbl::zeo amyE::(P<sub>hyspank</sub>-mprF, spc)</italic></td><td align="left" valign="middle">AK045B → AG304 cells</td></tr><tr><td align="left" valign="middle">AG1593</td><td align="left" valign="middle"><italic>trpC2 ΔmreBH::kan</italic></td><td align="left" valign="middle">BGSC strain* → 168CA cells</td></tr><tr><td align="left" valign="middle">AG1594</td><td align="left" valign="middle"><italic>trpC2 ΔugtP::kan</italic></td><td align="left" valign="middle">BGSC strain* → 168CA cells</td></tr><tr><td align="left" valign="middle">AG1604</td><td align="left" valign="middle"><italic>trpC2 ΔponA Ωneo ΔmreB</italic></td><td align="left" valign="middle">KS36 → RE101 cells</td></tr><tr><td align="left" valign="middle">AG1605</td><td align="left" valign="middle"><italic>trpC2 ΔponA Δmbl::zeo</italic></td><td align="left" valign="middle">AK045B → RE101 cells</td></tr><tr><td align="left" valign="middle">AG1643</td><td align="left" valign="middle"><italic>trpC2 ΔugtP::kan amyE::(P<sub>hyspank</sub>-lytE, spc)</italic></td><td align="left" valign="middle">AG1594 → AG475 cells</td></tr><tr><td align="left" valign="middle">AG1663</td><td align="left" valign="middle"><italic>trpC2 ΔmprF::kan</italic></td><td align="left" valign="middle">BGSC strain* → 168CA cells</td></tr><tr><td align="left" valign="middle">AG1667</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyfnI::erm amyE::(P<sub>hyspank</sub>-lytE, spc) ΔmprF::kan</italic></td><td align="left" valign="middle">AG1663 → AG1497 cells</td></tr><tr><td align="left" valign="middle">AG1668</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyqgS::erm amyE::(P<sub>hyspank-</sub>lytE, spc) ΔmprF::kan</italic></td><td align="left" valign="middle">AG1663 → AG1498 cells</td></tr><tr><td align="left" valign="middle">AG1669</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat ΔyfnI::erm amyE::(P<sub>hyspank-</sub>lytE, spc) ΔmprF::kan</italic></td><td align="left" valign="middle">AG1663 → AG1499 cells</td></tr><tr><td align="left" valign="middle">AG1670</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyfnI::erm amyE::(P<sub>hyspank</sub>-lytE, spc) ΔugtP::kan</italic></td><td align="left" valign="middle">AG1594 → AG1497 cells</td></tr><tr><td align="left" valign="middle">AG1671</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyqgS::erm amyE::(P<sub>hyspank-</sub>lytE, spc) ΔugtP::kan</italic></td><td align="left" valign="middle">AG1594 → AG1498 cells</td></tr><tr><td align="left" valign="middle">AG1672</td><td align="left" valign="middle"><italic>trpC2 ΔyqgS::cat ΔyfnI::erm amyE::(P<sub>hyspank-</sub>lytE, spc) ΔugtP::kan</italic></td><td align="left" valign="middle">AG1594 → AG1499 cells</td></tr><tr><td align="left" valign="middle">AG1673</td><td align="left" valign="middle"><italic>trpC2 ΔltaS::cat ΔyqgS::spc ΔmprF::kan</italic></td><td align="left" valign="middle">AG1663 → AG593 cells</td></tr><tr><td align="left" valign="middle">AG1675</td><td align="left" valign="middle"><italic>trpC2 ΔyfnI::erm ΔyqgS::spc ΔmprF::kan</italic></td><td align="left" valign="middle">AG1663 → AG595 cells</td></tr><tr><td align="left" valign="middle">AG1684</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>) <italic>amyE::(P<sub>hyspank</sub>-mprF, spc)</italic></td><td align="left" valign="middle">AG304 → AG587 cells</td></tr><tr><td align="left" valign="middle">AG1685</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΩlytE-his<sub>12</sub></italic>::(pMUTin-<italic>`lytE, erm</italic>) <italic>ΔugtP::kan</italic></td><td align="left" valign="middle">AG1594 → AG587 cells</td></tr><tr><td align="left" valign="middle">AK045B</td><td align="left" valign="middle"><italic>trpC2 Δmbl::zeo</italic> (in 168CA background)</td><td align="left" valign="middle">H. Strahl’s lab, A. Koh</td></tr><tr><td align="left" valign="middle">Dap<sup>R</sup>1</td><td align="left" valign="middle">DAP-resistant isolate derived from 168 1A1</td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R54">54</xref>)</td></tr><tr><td align="left" valign="middle">Dap<sup>R</sup>20</td><td align="left" valign="middle">DAP-resistant isolate derived from 168 1A1</td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R54">54</xref>)</td></tr><tr><td align="left" valign="middle">DLT71CA</td><td align="left" valign="middle"><italic>trpC2 dltAB::cat</italic></td><td align="left" valign="middle">DLT71 (<xref ref-type="bibr" rid="R40">40</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">DPVB45CA</td><td align="left" valign="middle"><italic>trpC2 ΔpbpG::kan</italic></td><td align="left" valign="middle">DPVB45 (<xref ref-type="bibr" rid="R80">80</xref>) → 168CA</td></tr><tr><td align="left" valign="middle">HB15507</td><td align="left" valign="middle">Dap<sup>R</sup>20 <italic>pgsA</italic><sup>WT</sup></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R54">54</xref>)</td></tr><tr><td align="left" valign="middle">HB15516</td><td align="left" valign="middle">Dap<sup>R</sup>1 <italic>pgsA</italic><sup>WT</sup></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R54">54</xref>)</td></tr><tr><td align="left" valign="middle">K532</td><td align="left" valign="middle"><italic>trpC2 lacA::cat</italic></td><td align="left" valign="middle">D. Claessen, unpublished</td></tr><tr><td align="left" valign="middle">KS36</td><td align="left" valign="middle"><italic>trpC2 Ωneo ΔmreB</italic> (in 168CA background)</td><td align="left" valign="middle">H. Strahl’s lab, K. Seistrup</td></tr><tr><td align="left" valign="middle">PDC620</td><td align="left" valign="middle"><italic>trpC2 aprE::(P<sub>spac</sub>-lytE, erm)</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R43">43</xref>)</td></tr><tr><td align="left" valign="middle">PDC702</td><td align="left" valign="middle"><italic>trpC2 ΔlytE::cat::spc aprE(::P<sub>xyl</sub>-lytE erm)</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R43">43</xref>)</td></tr><tr><td align="left" valign="middle">PG253</td><td align="left" valign="middle"><italic>trpC2 ΔugtP::spc</italic></td><td align="left" valign="middle">P. Gamba, unpublished</td></tr><tr><td align="left" valign="middle">RE101</td><td align="left" valign="middle"><italic>trpC2 ΔponA</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R12">12</xref>)</td></tr><tr><td align="left" valign="middle">RE102</td><td align="left" valign="middle"><italic>trpC2 ΔpbpF</italic></td><td align="left" valign="middle">pG<sup>+</sup>host10::<italic>ΔpbpF</italic> (<xref ref-type="bibr" rid="R12">12</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">RE103</td><td align="left" valign="middle"><italic>trpC2 ΔpbpD</italic></td><td align="left" valign="middle">pG<sup>+</sup>host10::<italic>ΔpbpD</italic> (<xref ref-type="bibr" rid="R12">12</xref>) → 168CA cells</td></tr><tr><td align="left" valign="middle">RE104</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD</italic></td><td align="left" valign="middle">pG<sup>+</sup>host9::<italic>ΔponA</italic> (<xref ref-type="bibr" rid="R12">12</xref>) → RE103 cells</td></tr><tr><td align="left" valign="middle">SM08</td><td align="left" valign="middle"><italic>trpC2 ΔgtaB::erm</italic></td><td align="left" valign="middle">S. Moore, unpublished</td></tr><tr><td align="left" valign="middle">SM31</td><td align="left" valign="middle"><italic>trpC2 ggaAB::spc</italic></td><td align="left" valign="middle">S. Moore, unpublished</td></tr><tr><td align="left" valign="middle">SM50</td><td align="left" valign="middle"><italic>trpC2 Ωerm ΔtagE</italic></td><td align="left" valign="middle">S. Moore, unpublished</td></tr><tr><td align="left" valign="middle">SSB122</td><td align="left" valign="middle"><italic>trpC2 pgcA (yhxB)::tet</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R81">81</xref>)</td></tr><tr><td align="left" valign="middle">SWA11a</td><td align="left" valign="middle"><italic>trpC2 ΔponA ΔpbpD ΔpbpF lacA::cat mprF::TnYLB-1(kan)</italic></td><td align="left" valign="middle">This study</td></tr><tr><td align="left" valign="middle" colspan="3"><italic><bold>S. aureus</bold></italic></td></tr><tr><td align="left" valign="middle">SA113</td><td align="left" valign="middle">SA113 (wild type, methicillin-sensitive)</td><td align="left" valign="middle">T. Palmer, lab collection</td></tr><tr><td align="left" valign="middle">SA113 <italic>ΔmprF</italic></td><td align="left" valign="middle">SA113 <italic>ΔmprF::erm</italic></td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R21">21</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>a</label><p id="P75">Antibiotic resistance to <italic>spc</italic>, spectinomycin; <italic>kan</italic>, kanamycin; <italic>erm</italic>, erythromycin; <italic>neo</italic>, neomycin; <italic>cat</italic>, chloramphenicol; <italic>tet</italic>, tetracyclin; <italic>zeo</italic>, zeocin and <italic>phleo</italic>: phleomycin. <italic>TnYLB-1(kan)</italic> transposon that originates from pMarB (<xref ref-type="table" rid="T1">Table 1</xref>). <italic>his<sub>12</sub></italic>indicates a coding sequence that corresponds to a 12 His tag at the C terminus. <italic>P<sub>hyspank</sub></italic> and <italic>P<sub>spac</sub></italic> are IPTG-inducible promoters with <italic>P<sub>hyspank</sub></italic> known to be stronger. Other abbreviations: Δ, deletion; Ω, insertion.</p></fn><fn id="TFN3"><label>b</label><p id="P76">Arrows indicate how the strain was constructed by transformation using either a plasmid DNA, a chromosomal DNA (strain code is then indicated) or a PCR on chromosomal DNA. BGSC* refers to the deletion mutant collection of the Bacillus Genetic Stock Center (<xref ref-type="bibr" rid="R82">82</xref>).</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><title>Primers used in this study</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle">Primer name</th><th align="left" valign="middle">Sequence (in bold restriction enzyme site)</th><th align="left" valign="middle">Used for<sup><xref ref-type="table-fn" rid="TFN4">a</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="middle">oAA01</td><td align="left" valign="middle">TTTTTCACCTTAATGCTTTGCATGGTATA TCTCCTTCTTAAAGTTAAACAAAATTATT TCTAGAGG</td><td align="left" valign="middle">To amplify pET28a (+)</td></tr><tr><td align="left" valign="middle">oAA02</td><td align="left" valign="middle">ACCTCGGTGCGAAAAGATTCCACCACCA CCACCACCACT</td><td align="left" valign="middle">To amplify pET28a (+)</td></tr><tr><td align="left" valign="middle">oAA03</td><td align="left" valign="middle">TAAGAAGGAGATATACCATGCAAAGCAT TAAGGTGAAAAAAGGCGAC</td><td align="left" valign="middle">To amplify <italic>lytE</italic> from base 76<sup>th</sup>-1002<sup>th</sup></td></tr><tr><td align="left" valign="middle">oAA04</td><td align="left" valign="middle">CAGTGGTGGTGGTGGTGGTGGAATCTTTT CGCACCGAGGTAACG</td><td align="left" valign="middle">To amplify <italic>lytE</italic> from base 76<sup>th</sup>-1002<sup>th</sup></td></tr><tr><td align="left" valign="middle">oAA05</td><td align="left" valign="middle">ACGCCGAAACAAGCGCTC</td><td align="left" valign="middle">To check pET28a-<italic>lytE-his</italic> plasmid</td></tr><tr><td align="left" valign="middle">oAA06</td><td align="left" valign="middle">GCTAGTTATTGCTCAGCG</td><td align="left" valign="middle">To check pET28a-<italic>lytE-his</italic> plasmid</td></tr><tr><td align="left" valign="middle">oAG18</td><td align="left" valign="middle">GTTGACTTTATCTACAAGGT</td><td align="left" valign="middle">To check insert cloned in pLOSS-<italic>P<sub>spac</sub></italic>-<italic>lytE</italic></td></tr><tr><td align="left" valign="middle">oAG19</td><td align="left" valign="middle">GGTACCAGTAGTTCACCAC</td><td align="left" valign="middle">To check pLOSS-<italic>P<sub>spac</sub></italic>-<italic>lytE</italic></td></tr><tr><td align="left" valign="middle">oAG81</td><td align="left" valign="middle">GAATCGCCTGGCTCACATCATC</td><td align="left" valign="middle">To check <italic>B. subtilis mprF::</italic>TnYLB-1</td></tr><tr><td align="left" valign="middle">oAG82</td><td align="left" valign="middle">CGGCAAAGAACAGTCCCAAG</td><td align="left" valign="middle">To check <italic>B. subtilis mprF::</italic>TnYLB-1</td></tr><tr><td align="left" valign="middle">oAG103</td><td align="left" valign="middle">CCTGTATGTCTGGCACTCAC</td><td align="left" valign="middle">To amplify upstream <italic>mprF</italic></td></tr><tr><td align="left" valign="middle">oAG104</td><td align="left" valign="middle">GC<bold>TCTAGA</bold>TGGTCTCTCCAATCATATTC</td><td align="left" valign="middle">To amplify upstream <italic>mprF</italic> (<italic>Eco</italic>RI)</td></tr><tr><td align="left" valign="middle">oAG105</td><td align="left" valign="middle">CG<bold>GAATTC</bold>TAAGACGGAGTCTTTTTTTAT TTCG</td><td align="left" valign="middle">To amplify downstream <italic>mprF</italic> (<italic>Xba</italic>I)</td></tr><tr><td align="left" valign="middle">oAG106</td><td align="left" valign="middle">CGGAGATGCGAGAGGGTTTC</td><td align="left" valign="middle">To amplify downstream <italic>mprF</italic></td></tr><tr><td align="left" valign="middle">oAG107</td><td align="left" valign="middle">TGCGGCATGCTCATATCCAG</td><td align="left" valign="middle">To check <italic>B. subtilis ΔmprF</italic></td></tr><tr><td align="left" valign="middle">oAG108</td><td align="left" valign="middle">TGGGCCAATCAGTGGACAAG</td><td align="left" valign="middle">To check <italic>B. subtilis ΔmprF</italic></td></tr><tr><td align="left" valign="middle">oAG124</td><td align="left" valign="middle">CCATCATCTGGTGCGAAAGG</td><td align="left" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="R12">12</xref>), to check <italic>B. subtilis ΔponA</italic></td></tr><tr><td align="left" valign="middle">oAG125</td><td align="left" valign="middle">CCGCAAAGCCGATTAATTGG</td></tr><tr><td align="left" valign="middle">oAG126</td><td align="left" valign="middle">TCTATTGGCGAGTGCTTC</td><td align="left" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="R12">12</xref>), to check <italic>B. subtilis ΔpbpF</italic></td></tr><tr><td align="left" valign="middle">oAG127</td><td align="left" valign="middle">AGCATCGACTCCGTATTG</td></tr><tr><td align="left" valign="middle">oAG128</td><td align="left" valign="middle">TTATTCGGAATGGCGATGGG</td><td align="left" valign="middle" rowspan="2">(<xref ref-type="bibr" rid="R12">12</xref>),to check <italic>B. subtilis ΔpbpD</italic></td></tr><tr><td align="left" valign="middle">oAG129</td><td align="left" valign="middle">CCTTAATGGCTGCAGTTGAC</td><td align="left" valign="middle">(<xref ref-type="bibr" rid="R12">12</xref>),to check <italic>B. subtilis ΔpbpD</italic></td></tr><tr><td align="left" valign="middle">oAG165</td><td align="left" valign="middle">CTAACCTGGCTGACATTCAC</td><td align="left" valign="middle">To check <italic>B. subtilis gtaB::</italic>TnYLB-1</td></tr><tr><td align="left" valign="middle">oAG166</td><td align="left" valign="middle">TGATCAGGTCTTCGCAGTTG</td><td align="left" valign="middle">To check <italic>B. subtilis gtaB::</italic>TnYLB-1</td></tr><tr><td align="left" valign="middle">oAG197</td><td align="left" valign="middle">GC<bold>TCTAGA</bold>GCACCCATTAGTTCAACAAA CG</td><td align="left" valign="middle">To amplify <italic>cat</italic> (<italic>Xba</italic>I)</td></tr><tr><td align="left" valign="middle">oAG198</td><td align="left" valign="middle">GC<bold>GGATCC</bold>AGTACAGTCGGCATTATCTC</td><td align="left" valign="middle">To amplify <italic>cat</italic> (<italic>Bam</italic>HI)</td></tr><tr><td align="left" valign="middle">oAG271</td><td align="left" valign="middle">GGG<bold>GTCGAC</bold>AAAGGAGATTCCTAGG<underline>AT</underline> <underline>G</underline>CTGATTAAAAAGAATGCT</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-mprF</italic></td></tr><tr><td align="left" valign="middle">oAG272</td><td align="left" valign="middle">GGG<bold>GCATGC</bold>TTGATGATATTGAAACCT</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-mprF</italic></td></tr><tr><td align="left" valign="middle">oAG300</td><td align="left" valign="middle">CAATCACGAAACAATAATTGG</td><td align="left" valign="middle">To check cloned insert in pDR111</td></tr><tr><td align="left" valign="middle">oAG301</td><td align="left" valign="middle">GTTGACTTTATCTACAAGGTG</td><td align="left" valign="middle">To check cloned insert in pDR111</td></tr><tr><td align="left" valign="middle">oAG308</td><td align="left" valign="middle">GGG<bold>GCTAGC</bold>AAAGGAGATTCCTAGG<underline>AT</underline> <underline>G</underline>AAAACATTTATAAAAGAAAGAGG</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-ltaS</italic> (<italic>Nhe</italic>I)</td></tr><tr><td align="left" valign="middle">oAG309</td><td align="left" valign="middle">CCG<bold>GCATGC</bold>CCGAATGTGGAATTTGC</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-ltaS</italic> (<italic>Sph</italic>I)</td></tr><tr><td align="left" valign="middle">oAG310</td><td align="left" valign="middle">GGG<bold>GCTAGC</bold>AAAGGAGATTCCTAGG<underline>AT</underline> <underline>G</underline>AAGAAACTTTTTTCTTACAAAC</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-yfnI</italic> (<italic>Nhe</italic>I)</td></tr><tr><td align="left" valign="middle">oAG311</td><td align="left" valign="middle">CCG<bold>GCATGC</bold>TGTAATGATATGAGAGAAA GC</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-yfnI</italic> (<italic>Sph</italic>I)</td></tr><tr><td align="left" valign="middle">oAG312</td><td align="left" valign="middle">GGG<bold>GCTAGC</bold>AAAGGAGATTCCTAGG<underline>AT</underline> <underline>G</underline>CGAAAAACGTTTTTTTCGAAG</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-yqgS</italic> (<italic>Nhe</italic>I)</td></tr><tr><td align="left" valign="middle">oAG313</td><td align="left" valign="middle">CCGGCATGCGAAAGCCTCCCGCTCACTT C</td><td align="left" valign="middle">To construct pDR111-<italic>P<sub>hyspank</sub>-yqgS</italic> (<italic>Sph</italic>I)</td></tr><tr><td align="left" valign="middle">oAG340</td><td align="left" valign="middle">GTCACATGAAGTCAAGACTATT</td><td align="left" valign="middle">To check Δ<italic>lytE</italic></td></tr><tr><td align="left" valign="middle">oAG341</td><td align="left" valign="middle">ACGGTTTATCAAGGAAGGACTC</td><td align="left" valign="middle">To check Δ<italic>lytE</italic></td></tr><tr><td align="left" valign="middle">oAG348</td><td align="left" valign="middle">GTG<bold>GCGGCCGC</bold>ATGAAAAAGCAAATCA TTACAG</td><td align="left" valign="middle">To construct pLOSS-<italic>P<sub>spac</sub></italic>-<italic>lytE</italic> (<italic>Not</italic>I)</td></tr><tr><td align="left" valign="middle">oAG349</td><td align="left" valign="middle">CCG<bold>GGATCC</bold>GATTGCCCTTTATGAAAAT AAG</td><td align="left" valign="middle">To construct pLOSS-<italic>P<sub>spac</sub></italic>-<italic>lytE</italic> (<italic>Bam</italic>HI)</td></tr><tr><td align="left" valign="middle">oAG350</td><td align="left" valign="middle">GTCTGTGCTTGAGGATAAGG</td><td align="left" valign="middle">To amplify upstream <italic>lytE</italic> for construction <italic>ΔlytE</italic></td></tr><tr><td align="left" valign="middle">oAG351</td><td align="left" valign="middle">GGG<bold>TCTAGA</bold>CTGCTGTCGTAGCTGTAAT G</td><td align="left" valign="middle">To amplify upstream <italic>lytE</italic> (<italic>Xba</italic>I) for construction <italic>ΔlytE</italic></td></tr><tr><td align="left" valign="middle">oAG352</td><td align="left" valign="middle">CCG<bold>GGATCC</bold>GCGAAAAGATTCTAATTTT TAG</td><td align="left" valign="middle">To amplify downstream <italic>lytE</italic> (<italic>Bam</italic>HI), for construction <italic>ΔlytE</italic></td></tr><tr><td align="left" valign="middle">oAG353</td><td align="left" valign="middle">GATCCGTTTGCGTGTTTC</td><td align="left" valign="middle">To amplify downstream <italic>lytE</italic>, for construction <italic>ΔlytE</italic></td></tr><tr><td align="left" valign="middle">oAG354</td><td align="left" valign="middle">GGG<bold>GAATTC</bold>GGCGGAACGACAACTTCA G</td><td align="left" valign="middle">To construct pMUTin-`<italic>lytE-his</italic>, amplify 3’ terminus <italic>`lytE</italic> (no stop codon)</td></tr><tr><td align="left" valign="middle">oAG355</td><td align="left" valign="middle">GGG<bold>CTCGAG</bold>GAATCTTTTCGCACCGAGG</td><td align="left" valign="middle">To construct pMUTin-<italic>`lytE-his</italic>, amplify 3’ terminus <italic>`lytE</italic> (no stop codon)</td></tr><tr><td align="left" valign="middle">oAG360</td><td align="left" valign="middle">GGC<bold>GAATTC</bold>GATTTATTCTCTAAAGACC ACG</td><td align="left" valign="middle">To construct pMUTin-<italic>`yfnI-his</italic>, amplify 3’ terminus <italic>`yfnI</italic> (no stop codon)</td></tr><tr><td align="left" valign="middle">oAG361</td><td align="left" valign="middle">GGG<bold>CTCGAG</bold>TTTGATTTCTTTCTCCTTGC CG</td><td align="left" valign="middle">To construct pMUTin-<italic>`yfnI-his</italic>, amplify 3’ terminus <italic>`yfnI</italic> (no stop codon)</td></tr><tr><td align="left" valign="middle">oAG366</td><td align="left" valign="middle">GGC<bold>GAATTC</bold>CGAAACGGAGACTTTATTT CAC</td><td align="left" valign="middle">To construct pMUTin-<italic>`ltaS-his</italic>, amplify 3’ terminus <italic>`ltaS</italic> (no stop codon)</td></tr><tr><td align="left" valign="middle">oAG367</td><td align="left" valign="middle">GGG<bold>CTCGAG</bold>TTTATCTTCGTTATCCTTTG AC</td><td align="left" valign="middle">To construct pMUTin-<italic>`ltaS-his</italic>, amplify 3’ terminus <italic>`ltaS</italic> (no stop codon)</td></tr><tr><td align="left" valign="middle">oAG368</td><td align="left" valign="middle">CAAGGTGTGGCATAATGT</td><td align="left" valign="middle">To check integration in pMUTinHis</td></tr><tr><td align="left" valign="middle">oAG369</td><td align="left" valign="middle">GACATCCAGAGGCACTTC</td><td align="left" valign="middle">To check integration in pMUTinHis</td></tr><tr><td align="left" valign="middle">oAG412</td><td align="left" valign="middle">CACCTGGTTTTCTGCTATAGT</td><td align="left" valign="middle">To check <italic>B. subtilis ΔgtaB</italic></td></tr><tr><td align="left" valign="middle">oAG413</td><td align="left" valign="middle">GTTTAACTCTACAATCAGTG</td><td align="left" valign="middle">To check <italic>B. subtilis ΔgtaB</italic></td></tr><tr><td align="left" valign="middle">PhleoXbaI-fw</td><td align="left" valign="middle">GC<bold>TCTAGA</bold>TCTTCCTTCAGGTTATGAC</td><td align="left" valign="middle">To amplify <italic>phleo</italic> from pIC22 (<italic>Xba</italic>I)</td></tr><tr><td align="left" valign="middle">PhleoEcoRI-rev</td><td align="left" valign="middle">C<bold>GAATTC</bold>CGCGCCCGATTGCTGAAC</td><td align="left" valign="middle">To amplify <italic>phleo</italic> from pIC22 (<italic>Eco</italic>RI)</td></tr><tr><td align="left" valign="middle">oAG686</td><td align="left" valign="middle">AAGAGAATGCGCCGGAACATC</td><td align="left" valign="middle">To amplify <italic>aprE</italic> locus and generate strain AG1676-1677</td></tr><tr><td align="left" valign="middle">oAG689</td><td align="left" valign="middle">TGACATTCGGCACACTCC</td><td align="left" valign="middle">To amplify <italic>aprE</italic> locus and generate strain AG1676-1677</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>a</label><p id="P77"><italic>cat</italic>, chloramphenicol resistance; <italic>phleo</italic>, phleomycin cassette; <italic>P<sub>spac</sub></italic> and <italic>P<sub>hyspank</sub></italic> are promoter inducible with IPTG, the latter is known to be stronger; <italic>rep<sub>pLS20</sub>(GA→CC)</italic>, unstable replication in <italic>Bacillus, TnYLB-1</italic> transposon associated to kanamycin resistance.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4</label><caption><title>Cell morphogenesis changes associated with deletion of LTA-synthase genes combined with class A PBPs null mutants of <italic>B. subtilis</italic></title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle">Strains<sup><xref ref-type="table-fn" rid="TFN5">a</xref></sup></th><th align="left" valign="middle">168CA</th><th align="left" valign="middle"><italic>Δ4</italic></th><th align="left" valign="middle"><italic>Δ4 ΔmprF</italic></th><th align="left" valign="middle"><italic>Δ4 ΔltaS</italic></th><th align="left" valign="middle"><italic>Δ4 ΔltaS ΔyfnI</italic></th><th align="left" valign="middle"><italic>Δ4 ΔltaS ΔyqgS</italic></th><th align="left" valign="middle"><italic>Δ4 ΔyfnI ΔyqgS</italic></th><th align="left" valign="middle"><italic>Δ4 ΔltaS ΔyfnI ΔyqgS</italic><sup><xref ref-type="table-fn" rid="TFN6">b</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="middle">average cell width (µm)</td><td align="center" valign="middle">0.8399</td><td align="center" valign="middle">0.6595</td><td align="center" valign="middle">0.6793</td><td align="center" valign="middle">0.6679</td><td align="center" valign="middle">0.7269</td><td align="center" valign="middle">0.7560</td><td align="center" valign="middle">0.6538</td><td align="center" valign="middle">0.7666</td></tr><tr><td align="left" valign="middle">stdev</td><td align="center" valign="middle">0.0469</td><td align="center" valign="middle">0.0492</td><td align="center" valign="middle">0.0546</td><td align="center" valign="middle">0.0550</td><td align="center" valign="middle">0.0528</td><td align="center" valign="middle">0.0499</td><td align="center" valign="middle">0.0513</td><td align="center" valign="middle">0.0529</td></tr><tr><td align="left" valign="middle">average cell lenght (µm)</td><td align="center" valign="middle">3.258</td><td align="center" valign="middle">4.557</td><td align="center" valign="middle">4.659</td><td align="center" valign="middle">4.828</td><td align="center" valign="middle">4.873</td><td align="center" valign="middle">4.926</td><td align="center" valign="middle">4.813</td><td align="center" valign="middle">5.312</td></tr><tr><td align="left" valign="middle">stdev</td><td align="center" valign="middle">0.787</td><td align="center" valign="middle">2.075</td><td align="center" valign="middle">2.180</td><td align="center" valign="middle">2.325</td><td align="center" valign="middle">2.240</td><td align="center" valign="middle">2.301</td><td align="center" valign="middle">1.926</td><td align="center" valign="middle">2.651</td></tr><tr><td align="left" valign="middle">cells counted</td><td align="center" valign="middle">437</td><td align="center" valign="middle">419</td><td align="center" valign="middle">399</td><td align="center" valign="middle">414</td><td align="center" valign="middle">426</td><td align="center" valign="middle">420</td><td align="center" valign="middle">423</td><td align="center" valign="middle">416</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><label>a</label><p id="P78">Average of cell width and cell length of strains 168CA, AG157 (<italic>Δ4</italic>), AG342 (<italic>Δ4 ΔltaS</italic>), AG377 (<italic>Δ4 ΔyfnI ΔyqgS</italic>), AG370 (<italic>Δ4 ΔltaS ΔyfnI</italic>), AG372 (<italic>Δ4 ΔltaS ΔyqgS</italic>), AG380 (<italic>Δ4 ΔltaS ΔyfnI ΔyqgS</italic>) and AG223 (<italic>Δ4 ΔmprF</italic>) analysed in <xref ref-type="supplementary-material" rid="SD1">Fig S3AB</xref>. Standard deviation (stdev) is indicated.</p></fn><fn id="TFN6"><label>b</label><p id="P79">Due to the formation of twisted cell chains, the cells measurement of <italic>Δ4 ΔltaS ΔyfnI ΔyqgS</italic> strain was done on the straight regions of the chain.</p></fn></table-wrap-foot></table-wrap></floats-group></article>